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ABSTRACT 
 
Background:  
HIV associated neurocognitive disorders (HAND), are a well-established consequence of HIV 
infection yet there is a lack of normative data required for diagnosis in Sub-Saharan Africa.  
Screening tools such as the International HIV dementia scale (IHDS) that are routinely used in 
the Sub-Saharan African region have questionable validity. This study investigates the use of 
the neuropsychological test battery in the detection of HAND in the absence of normative data. 
Further, the construct validity of the IHDS in the detection of HAND in the Ugandan context 
is examined. 
  
Methods  
Secondary data from a longitudinal Mental Health study carried out in Uganda were analysed. 
Information from a total of 1121 patients who underwent neuropsychological assessment in the 
main study qualified for the present study. A descriptive analysis of the neuropsychological 
performance of the study participants was conducted. To assess the relationship between 
demographic factors and the neurocognitive test scores of the neuropsychological test battery, 
multiple linear regression models were fitted. To determine how well the neuropsychological 
test battery predicted the IHDS score, a receiver-operating curve (ROC) analysis was 
conducted.  The construct validity of the IHDS in detecting HAND in the Ugandan population 
was then assessed using ROC analysis and published normative data. 
 
 
Results  
The total study population was 1,121 participants, with the majority being female (66.3%) 
while almost 62% had only primary school education. The mean age of the study participants 
was 35.0±9.3 years. Using the IHDS, 73.3% of the HIV infected patients were identified to be 
at risk of developing HIV associated dementia (HAD). Using the Frascati criteria and published 
normative data, only 9.1% of the HIV infected patients had HAND. Ageing, being female, 
having a lower socio-economic score and having lower levels of education were identified as 
predictors for poor neurocognitive performance. Poor performance in the neurocognitive 
measures to assess gross and fine motor function was directly proportional to poor performance 
in the IHDS (score ≥10 points). Better performance in the neurocognitive measures to assess 
verbal leaning/working memory and attention/working memory was directly proportional to 
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poor performance in the IHDS (score ≥10 points). The neurocognitive tests discriminated 
modestly between patients at risk of developing HAD and those that were not at risk of 
developing HAD (sensitivity=64.62%; specificity=66.67%). At the recommended cut-off score 
of 10 points, the IHDS had poor ability to identify patients with HAND (sensitivity=34.54%) 
and a high ability to identify patients without HAND (specificity=90.74%).  At a cut-off point 
of 7 points, the IHDS discriminated modestly between patients with HAND and those without 
(sensitivity=65.66%; specificity=58.52%).  
 
Conclusion  
The neuropsychological test battery used in the present study discriminated modestly among 
HIV patients at risk of developing HIV associated dementia and those that were not at risk of 
developing dementia. In the Ugandan population, the construct validity of the IHDS in the 
diagnosis of HAND was poor. Further work is required to produce an algorithm to detect 
HAND in the absence of normative data. This includes an inclusion of important clinical 
biomarkers, exploration of further demographic confounders as well strengthening of the 
HAND diagnostic criteria using the neuropsychological test battery.  
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CHAPTER 1: INTRODUCTION  
 
In this introductory chapter, the contextual background and literature review for the study are 
presented. The background section includes:    
1.1.1. A global overview of the HIV/AIDS pandemic 
1.1.2. A description of comorbid neurological complications associated with HIV  
1.1.3. A classification of HIV associated neurocognitive disorders (HAND) 
1.1.4. A description of the global epidemiology of HAND   
1.1.5. An overview of the detection of HAND 
1.1.6. A description of the epidemiology of HIV/AIDS in Uganda  
 
The background precedes the literature review where a detailed discussion of the challenges 
with HAND diagnosis in Sub-Saharan Africa (SSA) will be given. The conclusion of the 
chapter will culminate in the justification, aims and objectives of the study.  
 
1.1 Background 
 
1.1.1 Global overview of HIV/AIDS  
 
Since the emergence of the HIV/AIDS epidemic in 1981, approximately 70 million people 
have been diagnosed HIV positive, with the disease contributing substantially to the global 
burden of morbidity and mortality (1). Currently, the global prevalence of HIV is thought to be 
0.8% with young adults (in the age bracket 15 -49 years) disproportionately infected. More 
than 70% (25 800 000 individuals) of global infections are found in the Sub-Saharan African 
region (See Figure 1 below). 
 
2 
 
 
Figure 1: Global prevalence of the HIV/AIDS pandemic. 
 Adapted from: World Health Organization, 2016. Global Health Observatory (GHO) data. 
Available from: http://www.who.int/gho/hiv/en/. [03 March 2017]. 
 
 
1.1.2 HIV/AIDS and comorbid neurological conditions 
 
People living with HIV/AIDS (PLWHA) are at risk of several comorbid illnesses including 
pneumonia, tuberculosis (TB), diarrhoea and HIV associated neurological disorders (1,2). 
 
The HIV virus invades the brain during the early stages of infection where it replicates and 
mutates via migratory cells such as lymphoid cells (3). During this invasion, support cells in 
the brain known as microglia and astrocytes are infected (4). This in turn impairs nerve cells 
involved in cognitive control affecting one or more of the following cognitive domains: 
executive function, memory, attention, processing speed, visuospatial function, learning, 
reaction time and sensorimotor processes (5). A diagrammatic presentation of how HIV affects 
the neurocognitive domains of the brain is depicted in Figure 2 below. 
 
The term HAND is used to describe the spectrum of neurocognitive dysfunction in patients 
infected with HIV (6). Neurocognitive disorders are often strong predictors of morbidity and 
mortality (3,5,7,8). In a systematic review of HIV associated neurocognitive disorders, Saylor 
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and colleagues elucidate the disabling nature of HAND by describing the mechanism of HIV 
in the human brain in the early stage of HIV infection characterized by cerebrospinal fluid 
(CSF) inflammation that triggers neurodegeneration (9).  
 
 
1.1.3 Classification of HIV associated neurocognitive disorders  
 
HIV associated neurocognitive disorders  are classified into: Asymptomatic neurocognitive 
impairment (ANI), Mild neurocognitive disorder (MND) and the most severe, HIV associated 
dementia (HAD), (see Figure 2 below and Appendix A) (10).  
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Generated using Photoshop 
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Generated using Photoshop 
Figure 2: Brain regions implicated in HIV associated neurocognitive disorders 
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1.1.4 Global Epidemiology of HIV associated neurocognitive disorders 
 
Milder forms of HAND such as ANI and MND are reported to occur in 30-60% of individuals 
infected with HIV (11). Since the introduction of highly active antiretroviral therapy 
(HAART), the incidence of severe forms of HAND such as HAD has declined by 40%. Today 
HAD is reported to occur in 10-15% of all HIV infected individuals (11,12). Physical and social 
factors such as age, cardiovascular disease, education and gender have been reported to be 
associated with the development of HAND (9). Studies in developed settings such as the United 
States of America have reported a HAND prevalence of 42% while studies in developing 
settings such as Uganda have reported a HAND prevalence of 31% (10,13).  
 
1.1.5 Detection of HIV associated neurocognitive disorders  
 
There are several considerations to make when developing strategies for assessing 
neurocognitive impairment in people living with HIV/AIDS (PLWHA). These considerations 
include: life circumstances and cultural context of the study population, ease of 
instrument/assessment administration and validity of assessment instrument (14). It is for these 
reasons that screening tools such as the brief International HIV dementia scale (IHDS) have 
been identified as sufficient for identifying the presence/absence of neurocognitive impairment 
for primary healthcare settings. On the other hand, the neurocognitive test batteries that sample 
a wider range of cognitive ability are reserved for characterization of impairment in research 
settings in resource limited counties (15,16).  
 
In African countries, a battery of neurocognitive tests is commonly employed as the gold 
standard. The battery consists of the timed gait test- to assess gross motor function, the colour 
trails 1 test and the symbol digit modalities test- to assess speed of processing, the colour trails 
2 test- to assess executive functioning, the WHO-UCLA Auditory verbal learning test-to assess 
verbal learning and memory ability and the Digit span forward and backward test-to assess 
verbal learning and memory ability (12,17).  
 
The diagnostic criteria used in the classification of HAND are given in Figure 2 above. 
Administration of a battery of neurocognitive tests is often restricted to research settings due 
to the time-consuming and labour intensive nature of the tests as the tests can take up to four 
hours to administer (13). In addition, the use of neurocognitive tests to diagnose HAND 
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requires norms for the HIV seronegative population which are not readily available in resource 
limited settings such as Sub-Saharan-Africa (12,18). 
 
In clinical settings, screening tools such as the HIV dementia scale (HDS) and the International 
HIV dementia scale (IHDS) are most common (15). The most common screening tool in 
resource limited settings is the IHDS (12,15,16,19,20). In a preliminary report on HIV 
associated dementia, Tross et al. identified neurocognitive tests of motor speed, concentration 
and  memory to be prominently abnormal in patients with HIV dementia (21). This finding led 
to the development of an instrument designed to be rapid and sensitive in identifying dementia 
in HIV positive patients (19). Based on the findings by Tross et al, the IHDS was developed to 
identify deficits in the cognitive domains of motor function, concentration and memory (22). 
 
The IHDS consists of the following set of tests: the dominant finger tapping test and the non-
dominant Lauria- hand sequence test- to assess motor functioning as well as the four-word 
recall test- to assess memory and recall (19). These screening tools are effective in identifying 
participants at risk of developing the most debilitating form of HAND, HIV associated 
dementia (HAD), but are however not effective in identifying the category of cognitive 
impairment and moreover have questionable sensitivity and specificity as will be discussed 
later in the chapter (13,20). 
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1.1.6 Epidemiology of HIV/AIDS in Uganda 
 
The Ugandan HIV/AIDS epidemic has had an interesting transition. Uganda was one of the 
earliest African countries to be affected by the HIV/AIDS epidemic in the early 1980’s (23). 
By 2004, Uganda was considered a success in the arena of HIV/AIDS prevention particularly 
among younger cohorts and pregnant women attending antenatal surveillance sites. Several 
initiatives sought to encourage condom use and reduction in the number of sexual partners as 
well as increased access to anti-retroviral therapy (ART) (24). These efforts may have been 
associated with decline in HIV related mortality (24). In 2010, an estimated 67 000 Ugandans 
died from AIDS related illnesses. This declined in 2015 to 28 000 deaths.  
 
Today, however, in the Sub Saharan African region, Uganda is reported to have the third 
highest number of HIV infections after South Africa and Nigeria (25). Currently, the HIV 
prevalence in Uganda is 7% with an estimated 1.5 million PLWHA. Annual infections are 
projected to rise to 340 000 by the year 2025. It is challenging to elucidate the reasons for the 
increase in incidence of HIV infection in Uganda. Research has suggested that HIV related 
stigma and discrimination against PLWHA might have consequences for both the general 
population and PLWHA (26). HIV related stigma results in decreased uptake of HIV testing 
services and increased sexual risk behaviour in the general population. In PLWHA, HIV related 
stigma might impede access and adherence to ARV therapy (26). 
 
An increase in the incidence of HIV infection in Uganda may lead to an increase in the 
prevalence of comorbid neurological complications such as HAND (2). However, due to the 
absence of normative data and standardized HAND detection mechanisms in Sub Saharan 
Africa, it is difficult to elucidate the prevalence and incidence of HAND in Uganda. This 
prevents the development of appropriate medical interventions.  
 
To address the problem, it is of public health importance to establish innovative accurate means 
to screen for HAND in resource-limited settings in order to understand the prevalence and 
incidence of HAND within Sub Saharan Africa. Such innovative means would entail an 
assessment of the performance of the neurocognitive tests in the absence of normative data and 
an investigation on the comparative utility of the neurocognitive assessment tests and rapid 
screening tools such as the IHDS which we aim to tackle in the present study (17). 
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Although Sub-Saharan Africa has been reported to account for more than half of the HIV 
infections globally, the data on HAND in the region are variable or poor.  This paucity of data 
may be due to the lack of a comprehensive screening procedure, absence of normative data as 
well as variability in the validity of screening tools (15,27). Normative data is data obtained by 
administering a test to a reference population to establish norms. Norms are values that are 
representative of a certain population and are used as a baseline against which subsequently 
collected data is compared In the case of HAND, the reference population is an HIV negative 
population matched to the target HIV positive population for demographic factors such as age, 
education and gender (28). A detailed overview of studies aimed at attaining normative data in 
the Sub Saharan African region is presented in Table 1 below. 
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Table 1: Overview of HIV associated neurocognitive disorder normative data studies in 
sub Saharan Africa 
Authors Country Population 
characteristics  
Neurocognitive 
tests  
Comments  
Singh et al., 
2010 
South Africa  110 HIV 
seronegative 
participants, 
predominantly 
female, average 
10 years of 
education  
Digit span 
forward 
Digit span 
backward test  
Trail making 
test A  
Trail making 
test B 
Sample size 
relatively small 
hence findings not 
generalizable to the 
entire population. 
A brief 
neuropsychological 
test battery was 
used.  
Kelly et al., 
2014 
Malawi 103 HIV  
seronegative 
adults, median 
age 34.5 years, 
average 10.5 
years of 
education 
Hopkins verbal 
learning test 
WAIS digit 
symbol test 
Grooved 
pegboard 
dominant hand 
Grooved 
pegboard 
dominant hand 
Colour trails 1 
test 
Colour trails 2 
test  
Timed gait test  
Relatively small 
sample size. 
Normative data 
was not stratified 
by important 
demographic 
factors such as age, 
education and 
gender  
Robertson et 
al., 2016 
Brazil 
India 
Malawi 
Peru 
South Africa 
Thailand 
Zimbabwe  
2400 HIV 
seronegative 
adults were 
included in the 
multisite study. 
Mean age =35 
years. 50% 
female, average 
10 years 
education  
Hopkins verbal 
learning test 
Semantic verbal 
learning test   
WAIS digit 
symbol test 
Grooved 
pegboard 
dominant hand 
Grooved 
pegboard 
dominant hand 
Colour trails 1 
test 
Colour trails 2 
test  
Timed gait test 
There were 
substantial 
variations in 
neuropsychological 
performance across 
the different 
countries. This 
finding highlights 
the need for 
country based 
normative data. 
Cultural 
differences were 
suspected to 
account for 
variance in 
neuropsychological 
performance 
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1.2 Literature Review 
 
1.2.1 Search Strategies 
 
An extensive literature review was conducted in line with the study question of screening for 
HAND in the absence of normative data. 
 
The following databases were searched in discussion with my thesis supervisors: PubMed, 
Global Health, Clinical key and Scopus. The following keywords and several permutations 
were employed for the search strategy: “HIV associated neurocognitive disorders”, 
“International HIV dementia scale”, “HIV neuropsychological test battery”. MeSH terms were 
used to search each database. A total of 9043 abstracts were identified and extracted into a 
Mendeley database. Abstracts were filtered according to the inclusion and exclusion criteria 
outlined in table 2. The literature search was limited to journal articles published between the 
year 1991 and 2016 as the first standardized approach to diagnose neurocognitive deficits in 
HIV positive populations was first published in 1991. A flow diagram of the search strategy 
for this literature review is presented in figure 3 below. 
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Table 2: Inclusion and exclusion criteria for search strategy 
 
 Inclusion criteria Exclusion criteria  
Publication type Journal article (published 
between 1991-2016) 
English language  
 
Non-English journal article 
Pamphlets, editorials, 
guideline documents 
Study design Any study design in which 
the neuropsychological test 
battery and the 
International HIV 
dementia scale were used 
to detect HAND  
 
Study population  Adults (18 years and older)  
Condition of interest  HIV associated 
neurocognitive disorders 
Substance/alcohol  induced 
neurocognitive disorders 
 
 
 
Figure 3: Flow diagram for literature review search strategy 
 
 
Identification 
• Records identified from database search
•N= 9035
Screening 
• Records after duplicates removed 
•N=8915
Screening 
• Records screened
•N= 8915
Eligibility
• Full test articles assessed for eligibity
•N= 112
Included 
• Studies included for the literature review 
•N=49
Excluded
• Full text aricles excluded N=63
•no data on  neuropsyhcological testing, other screening test used instead of IHDS 
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The following themes emerged from the literature sourced:  
 Challenges associated with the neuropsychological test battery 
 Challenges associated with the IHDS  
The themes will be described in detail below.  
 
1.2.1.1 Challenges associated with the neuropsychological test battery   
 
The most frequently used procedure for the diagnosis of HAND in research settings in Africa 
is that prescribed by the American Academy of Neurology (AAN) in the year 2007 (10) with 
the battery of neurocognitive tests described earlier in the thesis. There are several challenges 
that exist in interpreting these neurocognitive tests in the Sub-Saharan African context, 
including: confounding effects of demographic factors, loosely defined diagnostic criteria, 
ambiguity in ANI diagnosis and the lack of normative data (17,28,29). 
 
The first challenge with the interpretation of neurocognitive tests is that it is suspected that 
demographic and cultural background could lead to the overestimation/underestimation of 
specific cognitive abilities (17). In a study conducted in the United States of America of a 
sample of 123 participants, ethnically diverse participants were compared with English 
speaking Anglo Americans. In this study English-speaking Anglo Americans were reported to 
outperform the ethnically diverse group (Boone et al., 2007). The study suggests that cultural 
familiarity with the testing format resulted in better performance in the WASIII symbol digit 
span and color trails tests for speed of information processing and attention abilities 
respectively (Boone et al., 2007). In addition, a study conducted in Australia revealed the 
following factors to contribute significantly to the proportion of variance in cognitive 
performance: age (13.8%), years of school (4.1%), culture (11.5%) and race (3%) (24). These 
findings lead us to strongly oppose the use of normative scores from Western settings to 
estimate HAND prevalence in Africa(28). In a conference for a review of the 
neuropsychological test battery, Anger et al. report that age and cultural differences affected 
the response time of adults in the neurocognitive assessment tests of the neuropsychological 
test battery which may affect estimation of HAND (Anger et al., 2000).  
 
Similarly, in a South African HIV clinical disease cohort, Singh et al found age and gender to 
influence neurocognitive function, with older individuals performing worse while the effect of 
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gender varied across the different tests (12). These studies highlight the confounding effect of 
demographic factors such as age, education and gender in the diagnosis of HAND. However, 
to date, adjustment for demographic factors in HAND studies in Sub-Saharan Africa is still 
limited. In Sub-Saharan African studies where there has been an attempt to generate normative 
data for HAND diagnosis, the confounding effects of demographic factors have been largely 
ignored and sample sizes are often too small to generate conclusive data on neuropsychological 
performance in African cohorts (12,18,30). In addition, studies on the African continent 
suggest that cultural heterogeneity across the different African countries prevents any cross 
cultural use of normative data (12,18,28). It is important to explore the effect of demographic 
factors on the neurocognitive performance of HIV clinical disease cohorts across different 
cultural contexts.  
 
The second challenge with the diagnosis of HAND using the neuropsychological test battery 
lies in the use of a broadly defined criteria to diagnose HAND which may lead to the rise of 
false positive results (29). The method of diagnosis proposed by the Frascati criteria (see 
Appendix A) is purely statistical and comes with recommendations that are not mandatory such 
as performing two tests per cognitive domain and at least 5 neurocognitive tests per individual 
(10). This loosely defined criterion has led to inconclusive prevalence reports in the region of 
Sub-Saharan Africa. For example, Lawler and colleagues conducted a cross sectional study of 
60 HIV positive individuals demographically matched to 80 control subjects in Botswana and 
found 37% of the HIV positive patients to be cognitively impaired in the following domains: 
speed of information processing, executive function, fine motor skills, verbal learning and 
memory (31). These findings on areas of cognitive impairment in HIV positive Sub-Saharan 
Africans were consistent with a Ugandan study by Robertson and colleagues where 110 HIV 
positive individuals and 100 control subjects were compared and the prevalence of HIV 
dementia was found to be 31%. However, in this study by Robertson and colleagues,  a brief 
test battery was used (only two neurocognitive tests) and patients were stratified by the 
Memorial Sloan Kettering dementia scale without adjustment for important demographic 
factors such as age, education and gender (30). In both studies, only single tests were performed 
per domain possibly due to the time-consuming nature of the tests. These studies raise the 
question on whether this generously defined criterion for HAND diagnosis has led to an 
overestimation of the burden of HAND. A standardized diagnostic procedure for HAND with 
mandatory guidelines is essential to rectify these problems (29). 
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The third challenge lies in the diagnosis of milder forms of HAND using neurocognitive tests. 
It seems ethically controversial to classify patients that do not have any symptoms as 
cognitively impaired. This is the case in the milder forms of HAND such as the Asymptomatic 
neurocognitive impairment (ANI) (10). In order to be diagnosed as an ANI case, patients need 
to have scored one standard deviation (1 SD) below the mean for demographically appropriate 
norms (10,17). This diagnostic criterion is questionable as there is currently no evidence to 
suggest that patients with ANI have an increased risk of developing more severe forms of 
HAND (29). The classification of patients as MND cases also needs to be taken with caution. 
This is due to the fact that there is a reliance on patients’ self-reports as to whether there is a 
change in functioning on their daily life activities. It is important to note that self-reports are 
subjective to the emotional state of the patient as well as other external factors such as study 
setting at the time of questioning  (Robertson et al., 2009). In a systematic review on cognitive 
dysfunction in HAND, it was revealed that self-reported functional abilities are often 
confounded by psychiatric and socio-economic factors. Depressed patients were reported to 
often over-report their functional impairment due to depressive symptoms while poor patients 
were likely to under-report their functional impairment to retain occupational responsibilities 
(8,32,33) 
 
Lastly, the greatest challenge with the diagnosis of HAND in SSA is the lack of normative data 
from a control population that is matched to the target population for at least culture/ethnicity, 
age, education and gender in order to effectively estimate the prevalence of HIV associated 
neurocognitive impairments (18,31). Studies that have been aimed at obtaining normative data 
for HAND are often limited by small sample sizes (12,14,34,35).  
 
Furthermore, the controversies that lie with attaining normative data include finding willing 
participants, considering the intense/time consuming nature of neuropsychological testing and 
the fact that it is difficult to match patients for all confounding factors that have been associated 
with HAND such as alcohol or drug abuse history (29). The absence of sophisticated 
technology such as neuroimaging techniques in resource limited settings to ascertain the 
absence/presence of neurocognitive impairment also poses as a limitation to finding the true 
prevalence of the disorders (36). In a recent study, Robertson and colleagues conducted a large 
scale multisite study to address the lack of normative data in resource limited settings. In this 
study 2400 HIV seronegative participants were enrolled from 7 resource limited countries 
including Brazil, Zimbabwe, Malawi, South Africa, India and Peru. However, there was a 
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marked variation in neuropsychological performance across different countries, which was 
suspected to be due to cultural diversity.    
 
1.2.1.2 Challenges associated with the International HIV dementia scale (IHDS) 
 
As described in the introduction above, the IHDS is widely used as a screening tool to identify 
patients at risk of developing HAD and patients who require further neuropsychological 
examination in resource limited settings (16). The instrument has also been increasingly used 
for the diagnosis of HAND in clinical settings despite the heterogeneity in accuracy reports 
(15,16). A great challenge in the detection of patients at risk of developing HAD using the 
IHDS is the uncertainty in the instrument validity for use in African cohorts. This is because 
literature on IHDS validity is limited by the lack of a standardized gold standard for HAND 
screening (13).  
 
Another reason for the uncertainty in IHDS validity is due to varying reference standards in 
different studies (15). In a study to establish the validity of the IHDS as a screening test for 
HIV dementia, Sacktor et al assessed 81 HIV positive Ugandans using the IHDS and a 
neuropsychological test battery. They found the sensitivity and specificity of the IHDS in 
detecting HIV dementia to be 80% and 57% respectively at a cut-off score of ≤ 10 (19). In a 
study conducted in a similar setting, 96 HIV seropositive individuals in South Africa underwent 
a similar assessment procedure. In this study, the sensitivity and specificity of the IHDS in 
detecting HAD was found to be 45% and 79% respectively at a cut off score of ≤10 (20). In a 
recent study in a Southern Chinese population of similar socio-economic status as the Ugandan 
population, 230 HIV infected patients underwent neuropsychological assessment and IHDS 
screening. In this case, IHDS was found to be an economical and well performing screening 
tool with sensitivity and specificity of 74% and 71% respectively at a cut-off score of ≤7.25 
(37). There is clear heterogeneity in validity reports on the IHDS emphasized in various papers 
(15,16,38).  
 
The above-mentioned studies employed varying strategies to strengthen validity. In the first 
study by Sacktor et al, the reference standard for ascertaining IHDS validity was the 
neuropsychological test battery with normative data from an HIV negative cohort. This cohort 
was significantly younger (mean age 31±7.3) than the HIV positive cohort (mean age 47±9.4), 
raising the question of whether age confounded the performance in these assessments   (14,19). 
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In the second study by Joska et al., (39) the reference standard for IHDS validity was the 
normative data adjusted for age, education and gender from neuropsychological tests. The 
adjustment for demographic factors highlighted these factors as independent determinants of 
neuropsychological performance. As this study by Joska et al. took the effect of confounding 
variables into account, the results  may have been more accurate in detecting HAND (20). In 
the third study by Dang et al, which reported the IHDS to be an effective screening tool in 
resource limited settings, the reference population also underwent neuroimaging to rule out 
CNS opportunistic infections in addition to neuropsychological assessment with adjustment for 
demographic factors (37). This strengthened the diagnosis of neurocognitive impairment 
specific to HIV hence strengthening the validity ascertainment of the IHDS in detecting these 
disorders. However, in this study by Dang et al, the cut off was much lower than in the other 
studies, significantly improving the sensitivity and specificity of the IHDS (29).  
 
Although the International recommendation for IHDS diagnosis is set at a cut off  ≤10 points 
for participants at risk of developing HAD, this recommendation does not consider the 
influence of age, education level, gender, ethnicity and cultural differences reported in some 
studies (20,37). A cut off of ≤ 10 points may introduce false positive results (37). There is still 
much work to be done by the scientific community in ascertaining the validity of the IHDS. In 
undertaking this task, a range of diagnostic cut-offs need to be explored and demographic 
differences in the IHDS performance need to be considered. Furthermore, due to the fact that 
the IHDS only tests performance on limited domains of motor function and memory/recall, a 
question arises about whether this tool is sufficient on its own in the diagnosis of HAD. Studies 
have suggested participants who perform poorly on the IHDS may perform well on 
neurocognitive assessment tests. This leads to a questioning of the validity of the IHDS in 
HAND detection (19,20).The comparative utility of the IHDS as a diagnosis tool for HAND 
with the neuropsychological test battery needs to be further explored. 
 
1.3 Problem Statement  
 
The concerns above highlight a gap in knowledge on HIV related neurocognitive impairment 
that exists in Sub-Saharan Africa. The large scale multisite study to obtain normative 
comparison data in diverse international resource limited settings by Robertson and colleagues 
revealed the need for country based normative data due to the neurocognitive variation 
observed across different cultural contexts (Robertson et al., 2016). However, this may not 
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always be feasible in the Sub-Saharan context where sample sizes for cognitive impairment 
studies are often limited by the intensity of the neurocognitive assessment methods hence 
limiting the availability of a normative group for comparison. Population norms are typically 
required to have a sample size of at least 1000 individuals (40). There is a need to explore 
mechanisms for the diagnosis of HAND in the absence of normative controls.  
 
 
1.4 Justification 
 
The above literature review suggests a paucity of conclusive normative data on HIV associated 
neurocognitive disorders in Sub-Saharan Africa. This study will therefore investigate the use 
of neurocognitive assessment tests described above in the diagnosis of HAND in the absence 
of normative data in Uganda. This will serve as a baseline for further exploration of innovative 
methods to diagnose HAND in the absence of normative data. Finding efficient mechanisms 
for the screening and diagnosis of HAND will assist early detection of the condition and the 
initiation of antiretroviral therapy that has been reported to dramatically decrease the incidence 
of severe forms of neurocognitive impairment hence curbing detrimental HIV outcomes and 
lessening the HAND health care system burden in Sub-Saharan Africa (41). 
 
1.5 Research question, aims and objectives 
 
Research question: Can existing neurocognitive assessment tests be used in the diagnosis of 
HAND in the absence of normative data in Uganda in 2012? 
 
Aim: To assess whether neurocognitive assessment tests can be used in the diagnosis of HAND 
in the absence of normative data in Uganda. 
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Objectives: 
 
1. To describe the neurocognitive assessment test scores (i.e. scores for the timed gait 
test, the WHO-UCLA verbal learning test, the grooved pegboard test, the colour 
trails 1 & 2 test, the Auditory verbal learning test, the digit span backward and 
forward test and the symbol digit modalities test) for each age, gender and education 
category among HIV-infected Ugandans using data collected from January 2012 to 
November 2012 in Masaka and Entebbe, Uganda. 
2. To investigate how each of the six neurocognitive test scores is related to age, 
gender and education, and to calculate age, gender and education adjusted scores 
among HIV-infected Ugandans using data collected from January 2012 to 
November 2012 in Masaka and Entebbe, Uganda. 
3. To determine the relationship between the seven neurocognitive assessment test 
scores and the International HIV Dementia Scale (IHDS) test score and to see how 
well the six scores predict the IHDS using data collected from January 2012 to 
November 2012 in Masaka and Entebbe, Uganda adjusting for age, education and 
gender. 
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CHAPTER 2: METHODS 
 
2.1. Study design  
 
The study is a cross sectional study design of baseline data nested within a longitudinal 
European & Developing Countries Clinical Trials Partnership (EDCTP) Mental Health study.  
 
2.2. Data source  
 
Data were provided by the Ugandan Medical Research Council/Uganda Virus Research 
Institute (MRC/UVRI). Professor Eugene Kinyanda is the Principal Investigator for the mental 
health study under which the baseline data for the present study is nested. The Ugandan 
MRC/UVRI Research Unit has been involved in several clinical studies on psychiatric and 
psychosocial complications of HIV/AIDS over the past 6 years, which have culminated in over 
40 publications in peer-reviewed journals. 
  
2.3 Study site 
 
The data were collected at the Aids Support Organization (TASO) Masaka and Entebbe clinics 
in Uganda by the MRC/UVRI Research Unit on AIDS in 2012. 
 
2.4 Study population  
 
The study population included consenting HIV positive participants (18 years and older) that 
were ART naïve and were registered as outpatients at the TASO Entebbe (semi-urban site) and 
TASO Masaka (rural site) clinics in Uganda in 2012.  
 
At the Entebbe study site, a random sample of 555 ART naïve HIV positive persons was 
recruited and at the Masaka study site, a random sample of 568 ART naïve HIV positive 
persons was recruited. The combined study sample size was 1127 participants; six observations 
were dropped due to the large amount of missing data resulting in an effective sample size of 
1121 participants. The study participants were identified by a unique study number that could 
not be linked to any personal identifiers. 
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2.5 Study sample  
 
All participants (18 years and older) who underwent neurocognitive evaluation in the TASO 
Entebbe and Masaka clinics were included in the present study. The exclusion criteria for the 
study included: participantswho had severe health problems that could prevent them from 
understanding the study instruments such as bed ridden cardiovascular disease participants and 
those who were unable to provide informed consent. 
  
2.6 Measuring instruments 
 
Data were collected using the EDCTP Mental Health study baseline questionnaire. The 
baseline questionnaire consisted of ten sections. The current study employed two sections from 
the baseline questionnaire i.e. the socio-demographics section and the HIV associated 
neurocognitive impairment section.  
 
Questionnaires were administered in the local language (Luganda). The data collection tools 
were back translated to meet a threshold reliability (42).  The following socio-demographic 
data were collected: study site, sex, marital status, religion, education level, occupation, date 
of birth and socio-economic index.  
 
Standardised locally translated neurocognitive assessment tools administered by psychiatric 
nurses were used to collect data on HIV associated neurocognitive impairment. For 
neurocognitive assessment, the following neurocognitive domains were measured: gross motor 
functioning (using the timed gait test), fine motor functioning (using the grooved pegboard 
test), speed of processing (using the colour trails 1 test and the symbol digit modalities test), 
executive functioning (using the colour trails 2  test), verbal learning and memory ability (using 
the WHO-UCLA Auditory verbal learning test) and attention/working memory (using the Digit 
span forward and backward test).  
 
A brief dementia screening tool known as the International HIV dementia scale (IHDS) was 
administered to identify participants at risk of developing HIV associated dementia (HAD), the 
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most severe form of HAND. The IHDS screening tool is made up of three tests used to assess 
motor functioning (using the dominant finger tapping test and the non-dominant alternating 
hand sequence test) and memory/recall (using the four-word recall test). (12,17). Data 
collected by the psychiatric nurses was entered into an MS ACCESS database (42). The data 
collection variables will be described in detail below.  
 
2.7 Measurement of variables  
 
The study variables used in the present study were grouped into four categories namely: 
demographic variables, neurocognitive assessment variables, dementia screening test variables 
and the Sheehan disability scale variables. The variables are described in detail below.  
 
2.7.1 Demographic variables 
 
 Study site: The study site was defined as either Entebbe or Masaka clinic. 
 Sex: This variable was defined as either ‘female’ or ‘male’.  
 Marital status: This is a nominal categorical variable with the following categories: 
‘married’, ‘widowed’, ‘separated/divorced’ and ‘single’. 
  Religion: This is a nominal categorical variable with the following categories: ‘Born 
again (converted to a personal faith in Jesus Christ)’, ‘Catholic’, ‘Muslim’, ‘Protestant 
(follower of any of the Western Christian churches that are separate from the Roman 
Catholic Church)’, ‘Seventh Day Adventist (SDA)’ (protestant Christian religion 
distinguished by its observation of Saturday as the day of worship) and ‘other’.  
 Education: This is an ordinal categorical variable with the following categories: 
‘none’, ‘primary’ and ‘secondary and above’. 
 Employment: This is a nominal categorical variable with the following categories: 
‘farmer or fisher’, ‘professional or clerical’, ‘trader or artisan or transport’ and 
‘unemployed or retired or housewife’. 
 Age: The age of the participant was calculated from the date of birth to the interview 
date. Age was recorded as a continuous variable 
 Socioeconomic score: This variable was derived from binary (yes/no) variables for 
ownership of the following consumer items: electricity, car, bicycle, radio, telephone, 
refrigerator, cupboard and flask. A principal components analysis was carried out to 
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recode the socioeconomic index as a variable taking values from 0 (for those who had 
no consumer items to 2.33 (for those who had all consumer items) (43). 
 
2.7.2 Neurocognitive assessment variables 
 
 The timed gait test score: The timed gait test was used to assess gross motor 
functioning. Participants were asked to walk a distance of 10 yards (9.14 meters) and 
return for a total of 20 yards (18.29 meters) as fast as possible. The time (in seconds) it 
took the participants to walk this distance was recorded and the score was rounded to 
the nearest full second. The timed gait test was administered for three trials. The total 
timed gait test score was the average of the three trials in seconds accurate to 1/10th of 
a second. If the participant required more than 45 seconds to complete trial, this trial 
was not considered and the mean time to complete test was calculated as the average of 
time for the completed trials (44). 
 
 The grooved pegboard test score: The grooved pegboard test was used to assess fine 
motor functioning. The pegboard consists of 25 slotted holes oriented in different 
directions. Participants were tested by how quickly they could slot the pegs into the 
holes. The pegs consisted of a square and rounded side. These pegs were to be rotated 
to match the hole on the pegboard before being inserted. The grooved pegboard test 
consisted of two subtests: the grooved pegboard dominant hand test and the grooved 
pegboard non-dominant hand test. Each subtest was dependant on whether a participant 
was left or right handed. For the right hand trial, pegs were required to be placed from 
participants left to right and the opposite applied for the left hand trial. Only one peg 
could be picked at a time. The score for each hand was the total time that the participant 
took to complete the entire board. If the participant took longer than 240 seconds to 
complete the entire board, the test was stopped. A total grooved pegboard score was 
calculated by adding the number of seconds it took to complete the dominant hand trial 
and the non-dominant hand trial (45).  
 
 The colour trails 1 test score: The colour trails 1 test was used to assess speed of 
processing. Participants were asked to make pencil line connections in numerical order 
between 25 encircled numbers which were randomly arranged (odd numbers were in 
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pink and even numbers were in yellow). The colour trails 1 test score was defined as 
the total time it took the participant to complete the test. 
 
 The colour trails 2 test score: The colour trails 2 test was administered to assess 
executive functioning. For this test, all numbers (1-25) were shown twice, once in pink 
and once in yellow. Participants were asked to connect in the numbers in sequential 
order alternating between colours. The colour trails 2 test score was defined as the total 
time it took the participant to complete the test. 
 
 The WHO_UCLA auditory verbal learning test (AVLT) score: The AVLT was 
used to assess verbal learning and memory recall. A list of 15 words was presented to 
the participant and the participant was required to recall as many items as possible from 
the list in any order. The test was repeated for a total of five trials. The list is read at a 
rate of one word per two seconds. For each word repeated correctly, a participant scored 
1 point. A total AVLT score was calculated by adding the total points from each of the 
five trials. The maximum score for the auditory verbal learning test is 75 points (46). 
 
 The Digit span test scores: The Digit span forward and backward tests were used to 
assess attention and working memory. The digit span forward test was administered 
separately from the digit span backward test. For the digit span forward test, participants 
were asked to repeat digits that the examiner recited to them. The digits were given at 
the rate of one per second with the pitch of the voice dropping on the last digit. The test 
was administered for a total of two trials. The test was discontinued after failure on both 
trials of any item. Each item was scored 2 points if the subject passed both trials, 1 point 
if the subject passed only one trial, 0 points if the subject failed both trials. The 
maximum score on the digit span forward test is 14 points. 
 
For the digit span backward test participants were asked to repeat digits that the 
examiner recited to them, however the participants had to repeat the digits backwards. 
Digits were read at a rate of one per second. The test was discontinued after failure on 
both trials of any item. Scoring of the digit span backward test is similar to the digit 
span forward test scoring. A total digit span score was generated by adding the score of 
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the digit span forward and the digit span backward test making a total maximum score 
of 28 points (46). 
 
 Symbol digit modalities test score: The symbol digit modalities test was used to assess 
speed of processing. Using a reference, each participant was given 90 seconds to pair 
specific numbers with specific symbols on a sheet of paper with empty boxes next to 
the numbers for the participant to fill in the symbol. The score of the symbol digit 
modalities test was the total number of correctly identified symbols. For this test, the 
maximum score a participant could get is 110 points (46). 
 
2.7.3 The dementia screening variables  
 
 IHDS scale score: The IHDS was used as a brief screening test for HIV dementia that 
provides information about verbal memory (using the four-word recall test), motor, and 
psychomotor speed performance (using the finger-tapping test and alternating hand 
sequence test respectively). The scale consisted of three components namely a four-
word memory recall test, a finger tapping hand test and an alternating hand sequence 
test with the non-dominant hand.   
 
To assess verbal memory, the four-word recall test was used. For this test, four words 
were recited to the participant and the participant was asked to repeat them 
immediately. The words were repeated by the examiner until the participant could 
repeat all four words correctly. The participant was then asked to recall the four words 
after the timed finger tapping and alternating hand sequence tests were performed. If 
the participant could not repeat the word, the examiner prompted semantic clues. 
Participants scored 1 point for each word repeated correctly and 0.5 points for a word 
recalled after prompting making a total maximum score of 4 points for the verbal 
memory test. 
 
For the finger-tapping test, the number of finger taps of the first two fingers of the non-
dominant hand were measured by instructing the participant to open and close the 
fingers as widely and as quickly as possible over a 5-second period. The participants 
were scored as follows; 4points for 15 taps in 5 seconds, 3 points for 11-14taps in 5 
seconds, 2 points for 7-10 taps in 5 seconds, 1 point for 3-6 taps in 5 seconds and 0 
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points for =0-2 taps in 5 seconds. The total maximum score for the finger-tapping test 
is 4 points. 
 
For the alternating hand sequence test, individuals were asked to perform the following 
movements with the non-dominant hand as quickly as possible over a 10-second period: 
(i) clench the hand in a fist on a flat surface; (ii) place the hand flat on the surface with 
the palm down; and (iii) place the hand perpendicular to the flat surface on the side of 
the fifth digit. The three hand positions were demonstrated by the examiner. The 
participants were scored as follows: 4 points for 4 sequences in 10 seconds, 3 points for 
3 sequences in 10 seconds, 2 points for 2 sequences in 10 seconds, 1 point for 1 
sequence in 10 seconds, 0 points if unable to perform test. 
A total IHDS score out of 12 was calculated for each participant, with each of the three 
tests contributing 4 points to the total score (19). 
 
2.7.4 Sheehan disability scale (SDS) variables 
 
 SDS score: The Sheehan disability scale is a brief self-report tool that was administered 
to participants to assess general functional impairment in the following interrelated 
fields: work life, family life and social life. Participants were asked to rate the extent to 
which their work, social and family life was impaired on a 10-point visual analogue 
scale. The general functional impairment SDS score was calculated by adding the three 
scores on work, social and family life to make a maximum total score of 30 points. A 
higher score indicated greater functional impairment. The instructions of the scale 
indicate that a patient who scores greater than five for any of the three scales has 
significant functional impairment (47).  
 
 
2.8 Main outcomes, exposures and potential confounders for each study objective 
 
Objective 1: To describe the neurocognitive assessment test scores (i.e. for the timed gait test, 
the grooved pegboard test, the color trails 1 test, the color trails 2 test, the WHO_UCLA test, 
auditory verbal learning test, the digit span test and the symbol digit modalities test for each 
age, gender and education category among HIV-infected Ugandans using data collected from 
January 2012 to November 2012 in Masaka and Entebbe, Uganda. 
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 Outcome variables: Neurocognitive assessment test scores  
 Exposure variables: Age, education, gender. 
 
Objective 2: To investigate how each of the seven neurocognitive assessment test scores is 
related to age, gender and education, and to calculate age, gender and education adjusted scores 
among HIV-infected Ugandans using data collected from January 2012 to November 2012 in 
Masaka and Entebbe, Uganda. 
 Outcome variables: the timed gait test, the grooved pegboard test, the color trails 1 test, 
the color trails 2 test, the WHO_UCLA auditory verbal learning test, the digit span test 
and the symbol digit modalities test. 
 Exposure variables: age, education and gender 
 Potential confounders: study site, marital status, religion, socioeconomic index, 
Sheehan disability score. 
 
Objective 3a: To determine the relationship between the seven neurocognitive assessment 
test scores and the International HIV Dementia Scale (IHDS) test score using data collected 
from January 2012 to November 2012 in Masaka and Entebbe, Uganda adjusting for age, 
education and gender. 
 Outcome variables: IHDS test score as an ordinal variable 
 Exposure variables: the following neurocognitive test scores adjusted for age, gender 
and education: the timed gait test, the grooved pegboard test, the color trails 1 test, the 
color trails 2 test, the WHO_UCLA auditory verbal learning test, the digit span test and 
the symbol digit modalities test. 
 
Objective 3b: To determine how well the seven neurocognitive assessment test scores predict 
the IHDS outcome using data collected from January 2012 to November 2012 in Masaka and 
Entebbe, Uganda adjusting for age, education and gender. 
 Outcome variables: IHDS outcome as a binary variable 
 Exposure variables: the timed gait test, the grooved pegboard test, the color trails 1 
test, the color trails 2 test, the WHO_UCLA auditory verbal learning test, the digit span 
test and the symbol digit modalities test adjusted for age, education and gender. 
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2.9 Data management and analysis 
 
The data were managed and analysed using STATA version 14 (Stata Corp, LP Texas USA). 
 
2.9.1 Data management 
 
To ensure that the statistical analysis programme operated on clean data, the data were taken 
through a process of data checking and data reduction.  
 
The data checking process included checking the data for any missing and miscoded data. For 
categorical variables, frequency tables were computed to assess if all the observations were 
related to the allowed category. For example, the allowed score range for each of the IHDS 
scores is 0-4, observations with values outside of this range were considered errors in 
recording.  For numeric/ continuous variables, normal probability plots were used to check for 
the distribution of the data. Six observations were dropped since more than 98% of the data 
were missing for these observations. Variables were labelled for ease of analysis and ease of 
result interpretation. 
 
The data reduction process included deriving categorical variables from continuous variables. 
For example, recoding the discrete variable, IHDS score into 3 categories. This step was done 
to create an ordinal outcome to fulfil objective 3a of the study, noting the variation in responses 
for certain answer choices on the IHDS scale, for example there were only two participants 
with an IHDS score of 2 points while there were 273 participants with an IHDS score of 10 
points.  
 
Following the process of data checking, the data was re-examined to check for errors and to 
gain an understanding of the study population characteristics. The initial sample size of 1127 
observations was reduced to 1121 following the data management process (observations that 
were dropped had no other data other than study site). Table 3 below shows a detailed 
description of the data management process for each study variable for the present study. 
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Table 3: Data management table 
 
No. Variable  Data management procedure Comment 
1 Study site  Cross tabulation  No missing observations (total 1127) 
2 Sex Cross tabulation  2 missing observations (both from Masaka) 
3 Marital status Cross tabulation 4 missing observations (1 from Entebbe, 3 from Masaka) 
4 Religion Cross tabulation 2 missing observations (both from Masaka) 
5 Education Cross tabulation 5 missing observations (1 from Entebbe, 4 from Masaka) 
6 Employment Cross tabulation 12 missing observations (7 from Entebbe, 5 from Masaka) 
7 Age  Probability distribution curve, 
variable summary  
Age range was 18-82, no outliers identified, normal distribution,  2 missing 
observations (both from Masaka) 
8 Socio-economic score Probability distribution curve, 
variable summary 
Range 0-2.33,  no outliers identified, normal distribution,  3 missing 
observations (all from Masaka) 
9 Timed gait score 
 
Generated from the average of 
3 trials.  
Probability distribution curve, 
variable summary 
As per test instructions, observations> 45 seconds must be dropped. One 
observation was dropped from trial 2 as it was identified as an outlier (>45 
seconds), an average of 2 trials was taken to generate timed gait score. 
Range 5.7-18, normal distribution,10 missing observations (4 from 
Entebbe, 6 from Masaka) 
10 Grooved pegboard total 
score  
Generated from the sum of the 
gpd and gpnd  
As per test instructions, observations > 240 seconds must be dropped. 
There were 3 such observations for the gpnd, and they were dropped Range 
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No. Variable  Data management procedure Comment 
Probability distribution curve, 
variable summary 
67-505, normal distribution, 19 missing observations (5 from Entebbe, 14 
from Masaka) 
11 Grooved pegboard 
dominant (gpd) hand 
score 
Probability distribution curve, 
variable summary 
Range 25-240, , no outliers identified, normal distribution, 14 missing 
observations  (4 from Entebbe, 10 from Masaka) 
12 Grooved pegboard 
(gpnd) non-dominant 
hand score 
Probability distribution curve, 
variable summary 
Range 25-240, 5 outliers identified (two of these took 2 seconds to 
complete the board (highly unlikely), 3 of these spend more than 240 
seconds and they were set as missing values, normal distribution,12 
missing observations (2 from Entebbe, 10 from Masaka) 
13 Colour trails 1 score Probability distribution curve, 
variable summary 
Range 28-320,  no outliers identified, normal distribution,  25 missing 
observations (10 from Entebbe, 15 from Masaka) 
14 Colour trails 2 score Probability distribution curve, 
variable summary 
Range 60-360, no outliers identified, normal distribution,  32 missing 
observations  (13 from Entebbe, 19 from Masaka) 
15 Auditory verbal 
learning test total score 
Probability distribution curve, 
variable summary 
Range 14-64, no outliers identified, normal distribution, 32 missing 
observations (13 from Entebbe, 19 from Masaka) 
16 Digit span total score  Generated from the sum of the 
dgspnf and dgspnb. 
Probability distribution curve, 
variable summary 
Range 1-22,  no outliers identified, normal distribution,  12 missing 
observations  (10 from Entebbe, 2 from Masaka) 
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No. Variable  Data management procedure Comment 
17 Digit span forward 
(dgspnf)score   
Probability distribution curve, 
variable summary 
Range 1-15,  no outliers identified, skewed normal distribution,  11 missing 
observations  (9 from Entebbe, 2 from Masaka) 
18 Digit span backward 
(dgspnb)score  
Probability distribution curve, 
variable summary 
Range 0-12,  no outliers identified, normal distribution,  12 missing 
observations  (10 from Entebbe, 2 from Masaka) 
19 Symbol digit 
modalities score 
Probability distribution curve, 
variable summary 
Range 1-90,  no outliers identified, skewed normal distribution,  63 missing 
observations  (32 from Entebbe, 31 from Masaka) 
20 IHDS score Generated from the average of 
four-word recall+finger 
tapping test+non-dominant 
hand alternating sequence test  
Probability distribution curve, 
variable summary 
Score was categorized into an 
ordinal variable for use in 
objective 3a 
Range 3.3-12, As per the scoring instructions each of the 3 subtests is 
scored out of 4 (see section 2.6.3). One observation had a score of 9 for the 
four-word recall test; this value was set as missing. skewed (p-0.0000), 12 
missing observations (6 from Entebbe, 6 from Masaka) 
IHDS score (ordinal outcome) categories were selected based in-order to 
meet the proportional odds assumption for the ordinal regression. 
Categories were selected ensuring that there were balanced proportions in 
the 3 categories (Category 1: score 3-8, Category 2: score >8-≤10, 
Category 3: >10-≤12 
21 IHDS_outcome  Binary outcome: 1= ‘at risk of 
developing HAD and 0= ‘not 
at risk of developing HAD’ 
Study participants were grouped into 2 categories i.e. those at risk of 
developing HAD (using prescribed criterion: IHDS score ≤10) and those 
not at risk of developing HAD (using prescribed criterion: IHDS score>10) 
(Sacktor et al., 2005)   
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No. Variable  Data management procedure Comment 
22 SDS score  Generated from the average of 
sdswork+sdsfamily+sdsscocial 
scales   
Probability distribution curve, 
variable summary 
Range 0-30, no outliers, normal distribution,  2 missing observations  (both 
from Masaka) 
23  HAND_outcome Binary variable generated 
using Frascati criteria 
specifications (See Appendix 
A) and published normative 
data (28) 
Study participants were grouped into 2 categories i.e. HAND cases (score 
of above 1 SD above the mean for age appropriate norms on two or more 
neurocognitive tests) and non-HAND cases (score within SD of specified 
appropriate norms) 
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2.9.2 Data analysis  
 
 2.9.2.1 Descriptive analysis  
 
2.9.2.1a Socio-demographic characteristics of study participants by study site 
 
The data consisted of eight demographic variables. The categorical demographic variables are 
study site, sex, marital status, religion, education and employment. The continuous 
demographic variables are age and socioeconomic index. To gain an understanding on the 
characteristics of the study population, cross tabulations (for the categorical variables) were 
computed to determine the proportion of the study population per demographic category. 
Central tendency measures were computed for the continuous variables. The results of the 
descriptive analysis for the study participants are presented in table 4. The data analysis plan 
for each objective is outlined below.  
 
2.9.2.1b Objective 1: Neuropsychological characteristics of the study participants 
 
The continuous variables included the seven neurocognitive tests, the IHDS score and the SDS 
score. To assess if the continuous variables approximately followed a normal probability 
distribution, a normal probability plot was plotted for each continuous variable (48). The 
normal probability plot was used to assess the normality of the data as the plot allows for large 
sample sizes as opposed to other statistical tests for normality that allow for limited ranges of 
sample sizes (Filliben, 2017; Shapiro, Wilk and Chen, 2017).The plots suggested that all 
continuous variables followed a normal distribution hence the mean±SD of the distribution of 
continuous variables were reported. To further assess the distribution of the data, the skewness 
and kurtosis tests were used. The results are presented in table 5. In accordance with the 
STROBE guidelines, inferential measures such as statistical tests of comparison e.g. t-test were 
not incorporated into the descriptive statistical analysis for this study (50). 
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2.9.2.2 Analytical analysis  
 
2.9.2.2a Objective 2: Relationship between demographic factors (age, gender and 
education) and neurocognitive test scores  
 
A multiple linear regression model was fitted to assess the association between demographic 
factors (exposure variables) and each of the neurocognitive tests (continuous outcome) using 
the equation below:  
 
Y =β0+ β1x1+ β2x2+… βnxn+ɛ 
Where: Y is the neurocognitive test scores for a given test  
  β0  is the intercept 
  β1 β2…. Βn are the regression coefficients for the explanatory variables  
  x1 x1…. xn are the explanatory variables i.e. age, gender, education etc.  
 
This model was fitted to assess how much variance in the neurocognitive test scores was 
explained by the demographic predictors. The linear regression analysis included a two-fold 
process of a multiple linear regression analysis with age, gender and education only and a 
multiple linear regression analysis with age, gender and education, adjusting for all other 
demographic factors. The reason for models with age, gender and education only was informed 
by previous studies in which these demographic factors were reported to be associated with 
neurocognitive performance (13). In the present study we aimed to explore this relationship. 
Multiple linear regression models were fitted to obtain age, gender and education adjusted 
scores. Age was treated as a continuous variable and centered for ease of intercept 
interpretation (51). The raw residuals for each test were then calculated by subtracting the fitted 
values from the observed values. The results of the multiple linear regression models to assess 
the relationship between age, gender, education and the neurocognitive test scores are 
presented in section 3.3.1 of the report. 
 
For the multiple linear regression analysis that incorporated all demographic factors, an 
interactive backward selection method which entailed a backward elimination process to 
reduce the predictors to those that can account for most of the variance in the dependent 
variable was used while forcing age, gender and education into the model. In this model, non-
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significant predictors were removed one at a time, starting with the factor that had the largest 
p-value, until all remaining factors had a two-sided p-value of less than 0.10 (52).  The 
interactive backward selection method was used in order to avoid the omission of negatively 
confounded sets of variables (i.e. two or more variables which must be included in the model 
as a set to control for confounding) which is a risk when using the forward and stepwise 
selection methods. All continuous variables were centered for ease of intercept interpretation 
(51). 
 
Prior to fitting the models, the assumptions for fitting a linear regression model were checked. 
These assumptions included: evidence of a linear relationship between the outcome variable 
and independent variable, response variable normality, no multicollinearity and 
homoscedasticity. To test the assumption of linearity between outcome and independent 
variable, a plot of standardized residuals versus the predicted Y values was computed. To 
assess the assumption of response variable normality, a normal probability plot was used. To 
test the assumption of no multicollinearity i.e. that independent variables are not correlated 
with each other, the VIF statistic was used. To test the assumption of homoscedasticity i.e. that 
the variance of error terms are similar across the independent variable, the Cook-Weisberg test 
for homogeneity was used. In instances where the linear regression assumptions were not met, 
the data was transformed. The Ramsey test was used to check if there was evidence of non-
linearity in the models assessing the relationship between the demographic factors and the 
neurocognitive tests. In instances where there was evidence of non-linearity, Multiple 
fractional polynomials were fitted to find the best power transformation (53). The results for 
the multi-linear regression models are presented in section 3.3.2. 
 
2.9.2.2b Objective 3a: Association between the six neurocognitive assessment tests and 
the IHDS test scores  
 
The outcome variable for this objective was the IHDS score as an ordinal outcome variable as 
described in Table 2.1 (variable 20). The explanatory variables were the neurocognitive test 
scores. For each neurocognitive score measured in seconds (i.e. grooved peg, colour trails 1 
&2), each score was divided by 20 for ease of interpretation. Univariable ordinal logistic 
regression models were fitted to assess the relationship between the scores of each independent 
neurocognitive test and the IHDS score. The raw residual test scores calculated removing the 
effect of age gender and education from the observed test scores were used for this section. A 
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multiple ordinal logistic regression model was fitted to assess the collective effect of the all the 
neurocognitive assessment tests (age, gender and education adjusted) on the IHDS score. The 
Brant test was used to check the proportional odds assumption (54). The odds of neurocognitive 
scores for the different IHDS score levels were found to be proportional (p=0.589). The results 
for this objective are presented in section 3.3.3 of the report. 
 
 
2.9.2.2c Objective 3b: Determining how well the neurocognitive assessment test scores 
predict the IHDS outcome 
 
To fulfill this objective, the variable ‘IHDS_outcome’ described in table 2 (variable 21) was 
used as the outcome (Sacktor et al., 2005). This variable classifies the study participants into 
two categories namely: participants at risk of developing HIV associated dementia (HAD) and 
participants that are not at risk of developing HAD. To determine how well the neurocognitive 
test scores, predict the IHDS outcome, univariable logistic regression models were fitted and a 
receiver operating curve (ROC) analysis was conducted. The logistic regression models were 
fitted to estimate the predicted probabilities to use as the classification variable in the ROC 
analysis. The ROC curve was used to estimate the area under the curve (AUC) and the optimum 
cut off points for the best tradeoff between sensitivity and specificity using the IHDS outcome 
as the reference variable. A parametric ROC curve was computed to estimate the AUC. The 
AUC was used to measure the ability of the neurocognitive tests to discriminate between 
individuals at risk of developing HAD and those that were not. A post estimation graph plot of 
the sensitivity/specificity versus probability cut-off was then plotted to obtain the optimal cut-
off point. The distribution of the neurocognitive tests did not follow a normal distribution hence 
a non-parametric estimation of the ROC curve was computed. The purpose of the non-
parametric estimation of the ROC curve was to tabulate the calculate sensitivities and 
specificities for each IHDS cut-off point. To evaluate the predictive accuracy of the models, 
with the highest AUC, and best trade-off between sensitivity and specificity were chosen (55).  
 
A multiple logistic regression model was then fitted to explore the combined predictive power 
of all the neurocognitive tests (age, gender and education adjusted) on the IHDS outcome. The 
ROC curve for this model was also computed following the steps used for the univariable 
models. The results of the ROC analysis are presented in section 3.4 of the report. 
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The high prevalence of HAD (i.e. participants identified to be at risk of developing HAD=73%) 
led to the questioning of the validity of the IHDS in this study population. Published normative 
data for HAND diagnosis in resource limited settings was then used to calibrate the cut-off 
scores for the neurocognitive test scores based on the Frascati criteria (see Appendix A) (28). 
Study participants were classified as either having HAND or not. The different categories of 
HAND were not specified however any participant with a score of 1 SD below the mean for 
age and education appropriate norms on two or more neurocognitive tests fit the description of 
a HAND diagnosis. For tests such as the timed gait score where a lower score meant better 
functioning, a score of above 1 SD above the mean for age appropriate norms on two or more 
neurocognitive tests was considered a HAND case. The selection of the normative data to use 
for the present study was justified by the similarity in study settings and similarity in age 
distribution (Age range for normative data study =18-85 years; mean age 35±12, age range for 
current study 18-82 years; mean age 35±9.32) (28). A ROC analysis to determine the validity 
of the IHDS in identifying HAND participantswas computed using the neurocognitive battery 
(HAND outcome) as the gold standard. A non-parametric and parametric ROC method was 
used. The parametric method included a graphical presentation of the sensitivity, specificity 
and probability cut-off. The non-parametric method tabulated calculated sensitivity and 
specificity for each cut-off point, this method was used allow for cut-off adjustment (55). The 
results are presented in section 3.5 of the report. 
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CHAPTER 3: RESULTS 
 
In this chapter, the results corresponding to each of the study objectives are presented.  
 
3.1 Socio-demographic characteristics of study participants by study site  
 
Table 4 presents the socio-demographic characteristics of the sample by study site. A total 
sample of 1127 HIV infected ART naïve participants were enrolled in the study. Participants 
with missing data on neurocognitive performance were excluded reducing the study sample to 
1121 participants. The TASO Masaka clinic had a higher number of participants (n=563) in 
comparison to the TASO Entebbe clinic (n=558).  
 
Socio demographic variables were compared across sites. Of the total study population, the 
majority of the participants were female (77.3%), a trend seen in both study sites. Slightly more 
than half of the study participants were married (51.4%). More than half of the participants 
were Catholic (52.9%). The distribution of participants by religious affiliation per study site 
showed that the TASO Masaka clinic had more Catholics (62.8%) in comparison to the TASO 
Entebbe clinic (43.2%). Almost 62% of the study participants had primary school education 
only. The proportion of primary school educated participants (i.e. had only primary school 
education) was higher in Masaka (69%) than in Entebbe (54.1%). In both study sites, i.e. most 
the participants were employed either as a farmer/fisher (29.4%) or as a 
trader/artisan/transporter (36.5%).  
 
The distribution of all the continuous variables was approximately normal. Therefore, the mean 
(SD) of the variables was reported. The mean age of the study participants in Masaka (37.1±9.3 
years) was higher than the mean age of the study participants in Entebbe (32.9±8.9 years). The 
overall mean age of all the study participants was 35.0±9.3 years and the mean socio-economic 
score was 1.2±0.6. 
 
The participants from the Masaka region which is predominantly rural were poorer than the 
participants from the Entebbe region as measured by the mean socio-economic score. The 
socio-economic score was based on the possession of a fixed number of assets (see section 
2.7.1), higher scores correspond to owning more assets with a minimum score of 0 and a 
maximum score of 2.33. The mean socio-economic score of the Masaka region was lower 
39 
 
(0.9±0.5) than the mean socio-economic index of the Entebbe region which had a mean socio-
economic index of 1.4±0.6.  
 
Table 4: Descriptive statistics of the socio-demographic characteristics of study 
participants by study site 
Characteristic  
 
 
Entebbe  
(N=558) 
N (%) 
Masaka  
(N=563) 
N (%)  
Total  
(N=1121) 
N (%) 
Sex  
Female 433 (77.6) 432 (77.0)) 865 (77.3) 
Male  125 (22.4) 129 (23.0) 254 (22.7) 
Marital status  
Married  298 (53.4) 276 (49.0) 574 (51.4) 
widowed  50 (9.0) 114 (20.3) 164 (14.7) 
Separated/divorced 134 (24.0) 136 (24.2) 270 (24.2) 
Single 75 (13.4) 34 (6.0) 109 (9.8) 
Religion  
Born again  66 (11.8) 30 (5.3) 96 (8.6) 
Catholic  241 (43.2) 351 (62.8) 592 (52.9) 
Muslim 71 (12.7) 96 (17.1) 167 (14.9) 
Protestant  163 (29.2) 81 (14.4) 244 (21.8) 
SDA  14 (2.5) 2 (0.4) 16 (1.4) 
    Other  3 (0.5) 1 (0.2) 4 (0.4) 
Education  
None 53 (9.5) 70 (12.4) 123 (11.0) 
Primary 302 (54.1) 389 (69.1) 691 (62.0) 
Secondary + 201 (36.2) 100 (17.8) 302 (27.1) 
Employment  
Farmer/fisher 75 (13.4) 251 (44.6) 326 (29.4) 
Professional/clerical 23 (4.1) 20 (3.6) 43 (3.9) 
Trader/artisan/transport 233 (41.8) 172 (30.6) 406 (36.5) 
Unemployment/retired/housewife 87 (15.6) 59 (10.5) 146 (13.2) 
Student/other  133 (23.8) 56 (10.0) 189 (17.0) 
 Mean±SD  Mean±SD  Mean±SD 
Age  32.9±8.9 37.1±9.2 35.0±9.3 
Socio-economic score 1.41±3.6 0.92±0.5 1.2±0.6 
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3.2 Neurocognitive characteristics of the study participants  
 
In table 5 below, a description of the distribution of the neurocognitive, dementia screening 
and global functional impairment test scores of the study population is given. The 
neurocognitive scores of the study participants were not symmetrical as suggested by the 
skewness values (skewness ≠0) and the difference in mean and median values (mean ≠median). 
A similar trend of asymmetry in the test scores can be seen for the dementia-screening test and 
the global functional impairment test.  
 
In comparison to the maximum possible score (45 seconds), the study participants seem to have 
scored fairly well in the timed gait test that assesses motor function (mean=11.9 ± 1.7).  
 
With regard to the grooved pegboard test to assess fine motor function, the overall average 
score for the study sample was fairly low (174.5 ± 49.9) in comparison to the maximum 
possible score (480 seconds) that the participants could potentially obtain.  
 
For the colour trails 1 & 2 tests to assess speed of processing and executive function 
respectively, the maximum possible score is not specified. However, a lower score suggests 
better function.  
 
The data from the colour trails 1 & 2 tests suggests that there was a positive skew for the 
distribution of both tests (skewness >0), hence there were a few individuals who obtained much 
higher scores than the remainder of the participants. The data on the digit symbol test to assess 
attention/working memory, suggests that the participants of the study had a fairly low 
attention/working memory rating when comparing the mean digit span total score (10.0 ± 3.3) 
to the maximum possible score (28 points). The overall speed of processing mean score for the 
study participants (18.1 ± 9.1) as assessed by the symbol digit modalities test was low in 
comparison to the maximum possible score (110 points).  
 
For the IHDS, a score of ≤10 indicates that participant is at risk of developing HIV associated 
dementia (HAD), the most severe form of HAND. The data on the IHDS score of the study 
participants show a mean score of 9.4 ± 1.5 and a median score of 10 (IQR=8.5-10.5) showing 
half of the study participants to be at borderline risk of developing HIV associated dementia 
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(HAD). There was an overall poor performance in the mean global functional impairment score 
of the study participants (4.56 ± 6.75) showing the study participants to have a decline in 
function in their work, social and family life. 
 
 
Table 5: Descriptive statistics of the neurocognitive characteristics of the study 
participants 
 
 
Characteristic  
 
Mean ± SD 
 
Median (IQR) 
 
Skewness 
 
Kurtosis 
  
Possible 
maximum 
score 
Neurocognitive tests   
Timed gait * 11.9 ± 1.7 12 (10-13) 0.2 3.4 45 
Grooved peg total* 174.5 ± 49.9 162 (144-188) 2.3 10.5 480 
grooved peg dominant hand* 77.8 ± 23.1 72 (64-86) 2.4 12.8 240 
grooved peg non-dominant hand* 96.9 ± 31.0 90 (78-105) 2.2 12.2 240 
Colour trails 1* 84.1 ± 34.8 77 (61-99) 2.1 10.6 ns 
Colour trails 2* 142.7 ± 51.8 128 (107-170) 1.3 5.0 n/a 
Auditory verbal learning   39.1 ± 7.7 39 (34-44) 0.2 3.0 75 
Digit span total  10.0 ± 3.3 10 (8-12) 0.5 3.4 28 
digit span forward  6.2 ± 2.2 6 (5-8) 0.4 3.2 14 
digit span backward  3.8 ± 1.6 4 (3-5) 0.5 4.0 14 
Symbol digit modalities* 18.1 ± 9.1 17 (12-22) 2.0 13.0 110 
Dementia screening test   
IHDS  9.4 ± 1.5 10 (8.5-10.5) 0.8 3.9 12 
Global functional impairment test  
SDS  4.56 ± 6.75 2 (0-6) 2.0 6.3 30 
For the tests marked with an asterisk*, a lower score indicates better function. 
n/a= not applicable 
The following test scores were recorded in seconds: timed gait, grooved pegboard dominant &non-dominant hand, colour trails 1&2 
The following test scores were recorded as points: digit span forward and backward, symbol digit modalities, IHDS and the SDS  
 
 
 
3.2.1 Neurocognitive characteristics of the study participants by age  
 
Age was associated with neurocognitive performance as seen in the variation in neurocognitive 
performance across the different participant ages shown in figure 4-12. However, the results 
suggest considerable residual variation.  The distribution of the timed gait scores shows that an 
increase in age corresponded with an increase in the time taken for the timed gait test and hence 
motor function declined with increasing age.  
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A similar trend of direct proportionality in the age of participants and neurocognitive tests is 
seen for the grooved pegboard test. This suggests that older participants had poorer fine motor 
function compared to younger participants.  
Further, the data suggest that older participants also had poor speed of processing (shown in 
figure 6 and figure 10) and executive function (shown in figure 7) in comparison to younger 
participants. There was an inverse relationship between age and Auditory verbal learning score. 
This suggests that as participants’ age, there was a decline in verbal learning/memory. As the 
age of the study participants increased, there was a gradual decline in the IHDS score, showing 
older participants to be more susceptible to developing HIV associated dementia. There was 
little to no variation in general functional impairment from ages 18-40 years, however, from 
age 50-80 years there was a slight variation in functional performance in the participant’s work, 
social and family lives. 
 
 
.  
Figure 4: Distribution of the timed gait score by age 
 
 
Figure 5: Distribution of the grooved pegboard overall score by age 
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Figure 6: Distribution of the colour trails 1 score by age 
 
Figure 7: Distribution of the colour trails 2 score by age 
 
 
Figure 8: Distribution of the Auditory verbal learning test score by age  
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Figure 9: Distribution of the digit span score by age 
 
Figure 10: Distribution of the symbol digit modalities score by age  
 
 
Figure 11: Distribution of the IHDS score by age 
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Figure 12: Distribution of the general functional impairment score by age  
 
3.2.2 Neurocognitive characteristics of the study participants by gender  
 
Table 6 below, presents the distribution of the neurocognitive test scores by participant’s 
gender. Female participants’ performance was not as strong as male participants in the tests 
that assessed the following cognitive domains: gross motor function (timed gait test), fine 
motor function (grooved pegboard test), speed of processing (colour trails 1 test), executive 
function (colour trails 2 test) and verbal learning/memory (digit span, forward and backward) 
as shown by the difference in the neurocognitive mean scores. Although male participants were 
shown to outperform female participants in the colour trails 1 test to assess speed of processing, 
this finding was contradicted by the results of the symbol digit modalities test which assesses 
the same cognitive function.  
 
From the symbol digit modalities mean test scores where a higher score indicated poorer 
cognitive function, female participants showed poorer verbal learning/memory function (18.2 
± 9.3) in comparison to male participants 17.8 ± 8.3. There was no difference in the mean test 
scores between the two genders for the digit span tests to assess attention/working memory. 
The mean score of the IHDS shows that both males and females were at similar risk of 
developing HAD. Male participants had a slightly higher score on general functioning in their 
work, social and family lives.  
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Table 6: Descriptive statistics of the neurocognitive characteristics of the study 
participants by gender 
 
 
Female  
Mean±SD  
Male 
Mean±SD 
Neurocognitive tests  
Timed gait * 12.07 ± 1.7 11.3 ± 1,6 
Grooved peg total * 176.4 ± 52.0 168.1 ± 41.1 
grooved peg dominant hand * 78.7 ± 23.7 75.2 ± 20.5 
grooved peg non-dominant hand * 98.0 ± 32.3 93.4 ± 25.7 
Colour trails 1 * 85.7 ± 36.1 78.9 ± 29.6 
Colour trails 2* 145.3 ± 53.0 134.1 ± 46.5 
Auditory verbal learning   39.4 ± 7.7 38.1 ± 7.7 
Digit span total  10.0 ± 3.3 10.0 ± 3.0 
digit span forward  6.2 ± 2.3 6.2 ± 2.0 
digit span backward  3.9 ± 1.6 3.8 ± 1.5 
Symbol digit modalities* 18.2 ± 9.3 17.8 ± 8.3 
Dementia screening test  
IHDS  9.4 ± 1.5 9.4 ± 1.6 
Global functional impairment test 
SDS  4.4 ± 6.6 5.0 ± 7.3 
*a lower test score indicates better function   
  
 
3.2.3 Neurocognitive characteristics of the study participants by education level   
 
The means and standard deviations of the study participants by education category are 
presented in table 7 below. There was a variation in the digit span test to assess 
attention/working memory, participants with a primary school education had a higher mean 
score (9.8 ± 3.0) showing poorer performance in comparison to participants with no education 
(mean score= 8.1 ± 3.3) and secondary+ educated participants (mean score= 8.0 ± 1.0). There 
was slight variation in the mean scores for the IHDS screening test across the different 
education levels, the mean IHDS test scores ranged between 9.1-9.4 points. As education level 
increased, the general functional impairment score decreased.  
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Table 7: Descriptive statistics of the neurocognitive characteristics of the study 
participants by education 
 
 
None  
Mean ±SD  
Primary  
Mean ±SD 
Secondary + 
Mean ±SD 
Timed gait * 12.5 ± 1.6 12.0 ± 1.6 10.67 ± 1.5 
Grooved peg total * 193.5 ± 59.4 177.1 ± 50.5 138.7 ± 67.5 
grooved peg dominant hand * 87.6 ± 30.8 78.5 ± 22.7 78.7 ± 19.5 
grooved peg non-dominant hand* 107.4 ± 35.4 98.9 ± 31.4 60 ± 51.4 
Colour trails 1 * 115.5 ± 53.8 85.6 ± 31.5 52 ± 8.7 
Colour trails 2* 175.7 ± 65.2 143.6 ± 50.4 95.3 ± 5.5 
Auditory verbal learning   37.1 ± 7.6 38.8 ± 7.4 41.3 ± 1.5 
Digit span total  8.12 ± 3.3 9.8 ± 3.0 8.0 ± 1.0 
digit span forward  5.2 ± 2.1 6.0 ± 2.1 3.7 ± 0.6 
digit span backward  3.0 ± 1.8 3.7 ± 1.5 4.3 ± 0.6 
Symbol digit modalities* 10.8 ± 5.6 16.8 ± 8.4 26 ± 8.0 
IHDS  9.0 ± 1.8 9.3 ± 1.4 9.1 ± 1.6 
SDS  4.7 ± 7.0 4.6 ± 7.0 1 ± 1.7 
*a lower test score indicates better function    
 
 
3.3 Association between age, gender, education and the neurocognitive test scores  
 
3.3.1 Multiple linear regression analysis for the association between age, gender, 
education and the neurocognitive test scores  
 
Table 8 shows the results of the multiple linear regression models fitted to examine the 
association between the factors: age, education and gender for each of the seven neurocognitive 
tests used in the study. For test scores with missing values (see table 3), observations were 
automatically dropped when the multiple regression model was fitted (56). Age was treated as 
a continuous variable and centred at the mean age of 35 years for ease of intercept 
interpretation. The results of the multiple regression model for each test are examined below.  
 
3.3.1.1 Association between age, gender, education and the timed gait test score  
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The relationship between age, education and gender and each of the seven neurocognitive test 
scores was modelled by the equations below:  
 Timed gait test score (seconds) = 12.20 + 0.05*age + 0.86*female_gender + 
0.29*no_education - 0.48*secondary_education 
 Grooved pegboard test score (seconds) = 178.71 + 1.27*age - 9.63*male+ 
14.41*no_education - 12.20*secondary_education 
 Colour trails 1 test score (seconds) = 86.81 + 0.43*age3 - 6.17*male + 
28.92*no_education - 15.10*secondary_education  
 Colour trails 2 test score (seconds) = 145.88 + 0.40*age -  10.53*male + 
30.83*no_education - 13.28*secondary_education  
 Auditory verbal learning test score (points) = 39.18 - 0.07*age - 1.21*male -
1.77*no_education + 3.35*secondary_education  
 Digit span test score (points) = 9.73 - 0.02*age - 0.08*male -1.63*no_education + 
1.59*secondary_education  
 Symbol digit modalities (points) = 16.52 - 0.07*age - 0.46*male-
6.13*no_education + 6.03*secondary_education  
 
Age, gender and education influenced the participant scores on gross motor function, fine 
motor function, speed of processing, executive function, verbal learning and attention as shown 
in the equations above and table 8 below.  
 
Aging, being female and lower education levels were identified as important predictors for 
neurocognitive impairment across all domains. The constants displayed in table 8 below 
indicate the average time taken to complete the test or average points scored by a 35-year-old 
male with a primary school education. Across all cognitive domains except for 
attention/working memory as measured by the digit span test and speed of processing as 
measured by the symbol digit modalities test, older participants displayed poorer cognitive 
function in comparison to younger participants. Speed of processing as measured by the colour 
trails 1 test shows older participants to perform better in this domain which is different from 
the results of the symbol digit modalities test which shows younger participants perform better 
than older participants in this domain (note the two tests measure the same cognitive domain). 
Male participants had better cognitive function in all cognitive domains as shown by the time 
taken for male participants to complete the timed gait, grooved pegboard, colour trails tests and 
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points scored in the auditory verbal learning, digit span and symbol digit modalities tests in 
comparison to female participants. An increase in the education level of the participants was 
associated with better cognitive function across all domains. The overall variation in each of 
the neurocognitive test scores that can be explained by the test scores linear relationship with 
age, gender and education ranged from 2.9%-16.0%.  
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Table 8: Multiple linear regression analysis for the association between age, education 
and gender and the neurocognitive tests scores 
 
The timed gait test* (cons=12.20 seconds) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) 0.05 (0.04-0.06) 0.01 0.000 
Gender:  
   
male compared to female -0.86 (-1.07--0.64) 0.11 0.000 
Education:  
   
None compared to primary 0.29 ( -0.01-0.59) 0.15 0.056 
secondary compared to primary  -0.48 (-0.69--0.26) 0.11 0.000 
*a lower test score indicates better function 
test score in seconds 
F=52.44; p=0.000; R2=15.98% 
The grooved pegboard test* (cons=178.71 seconds) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) 1.27 (0.96-1.57) 0.16 0.000 
Gender: 
   
male compared to female -9.63 (-16.40--2.87) 3.44 0.005 
Education: 
   
none compared to primary 14.41 (5.16-23.67) 4.72 0.002 
secondary compared to primary   -12.20 (-18.74--5.65) 3.34 0.000 
*a lower test score indicates better function  
test score in seconds 
F=28.16; p=0.000; R2=9.34% 
The colour trails 1 test* (cons=86.81 seconds) 
 
Unadjusted Coef (95% CI) Std error p-value 
Age (centred) 0.43 (0.22-0.64) 0.11 0.000 
Gender: 
   
male compared to female 6.17 (-10.76--1.58) 2.34 0.008 
Education:  
   
None compared to primary 28.92 (22.50-35.34) 3.27 0.000 
secondary+ compared to primary -15.10 (-19.50--10.69) 2.24 0.000 
*a lower test score indicates better function 
test scores in seconds 
F=48.53; p=0.000; R2=15.14% 
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The colour trails 2 test* (cons=145.88 seconds) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) 0.40 (0.07-0.72) 0.17 0.016 
Gender:  
   
male compared to female -10.53 (-17.68--3.37) 3.65 0.004 
Education: 
   
none compared to primary 30.83 (20.72-40.95) 5.16 0.000 
secondary compared to primary  -13.28 (-20.14--6.41) 3.50 0.000 
*a lower test score indicates better function 
test scores in seconds 
F=20.57; p=0.000; R2=7.07% 
The Auditory verbal learning test (cons=39.18 points) 
 
Adjusted Coef (95% CI) Std error p-value 
Age  -0.07 (-0.12--0.02) 0.02 0.004 
Gender: 
   
male compared to female -1.21 (-2.29--0.14) 0.55 0.027 
Education: 
   
none compared to primary -1.77 (-3.24--0.30) 0.75 0.018 
secondary compared to primary  3.35 (1.74-4.96) 0.82 0.009 
test scores in points  
F=8.37; p=0.000; R2=2.93% 
The digit span test (cons=9.73 points) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) -0.02 (-0.04--0.00) 0.10 0.018 
Gender: 
   
male compared to female 0.08 (-0.36-0.52) 0.22 0.711 
Education: 
   
none compared to primary -1.63 (-2.2--1.04) 0.30 0.000 
secondary compared to primary  1.59 (1.16-2.01) 0.22 0.000 
test scores in points 
F=29.58; p=0.000; R2=9.67% 
The symbol digit modalities test* (cons=16.52 points) 
 
Adjusted Coef (95% CI) Std error p-value 
Age  -0.07 (-0.17--0.05) 0.03 0.017 
Gender:  
   
male compared to female 0.46 (-7.98--4.29) 0.61 0454 
Education: 
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none compared to primary -6.13 (-7.98--4.29) 0.94 0.000 
secondary compared to primary 6.03 (4.89-7.19) 0.59 0.000 
*a lower test score indicates better function 
test scores in points 
F=49.27; p=0.000; R2=15.74% 
 
 
3.3.2 Multiple linear regression analysis for the association between demographic 
factors and the neurocognitive test scores  
 
The following demographic variables were considered as potential explanatory variables in 
the multiple linear regression models for the neurocognitive test scores: socio-economic 
index, Sheehan disability score, marital status, religion and study site. All models included 
age, education and gender as previous work has shown these factors to be associated with 
neurocognitive performance (18,20,37). Initially all potential explanatory variables were 
included in the model. Those that were not significant at the 10% level were removed in a 
backward elimination algorithm. The results for each regression model are presented below. 
 
3.3.2.1 Association between demographic factors and the timed gait test score 
 
The overall regression model was highly significant (F=57.82; p<0.001) with 30% of the 
variation in the timed gait test score accounted for by its linear relationship with the 
demographic factors listed in table 3.3.2.i below. Individuals from Masaka were likely to take 
1.25 seconds longer (showing worse gross motor function) to complete the timed gait test in 
comparison to individuals from the Entebbe study site.  Widowed and single participants took 
longer to complete to timed gait test in comparison to married participants.  
 
Table 9: Multiple linear regression analysis for the association between demographic 
factors and the timed gait test score 
 
The timed gait test * (cons=11.43 seconds) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) 0.04 (0.03-0.05) 0.01 0.000 
Gender:  
   
male compared to female -0.82 (-1.02--0.61) 0.10 0.000 
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Education:  
   
None compared to primary 0.31 (0.04-0.57) 0.14 0.031 
secondary compared to primary  -0.24 (-0.44--0.04) 0.10 0.025 
Study site:    
Masaka compared to Entebbe  1.25 (1.07-1.43) 0.09 0.000 
Sheehan disability score (centred) 0.01 (0.00-0.03) 0.01 0.033 
Marital status:    
Divorced compared to married  -0.07 (0.25-0.14) 3.59 0.490 
Single compared to married 0.26 (-0.03--0.55) 0.15 0.041 
Widowed compared to married  0.32 (0.05-0.58) 0.13 0.118 
*a lower test score indicates better function 
 F=57.82; p=0.000; R2=30.16% 
 
 
 
 
 
3.3.2.2 Association between demographic factors and the grooved pegboard test score 
 
Keeping all other demographic factors in the model constant, a unit increase in the socio-
economic score on average led to a 6.24 second decrease in the grooved pegboard score 
(p=0.001). Single participants on average took 12.72 seconds longer to complete the grooved 
pegboard test in comparison to married participants. The total variation in the grooved 
pegboard test score explained by its linear relationship with the demographic factors listed in 
table 10 below is 10.6%. The overall model was highly significant (F=17.61; p<0.001).  
 
 
 
Table 10: Multiple linear regression analysis for the association between demographic 
factors and the grooved pegboard test score 
 
The grooved pegboard test * (cons=177.38 seconds) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) 1.34 (1.02-1.65) 0.16 0.000 
Gender:  
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male compared to female -9.96 (-16.77--3.20) 3.44 0.004 
Education:  
   
None compared to primary 13.27 (4.00-22.54) 4.73 0.005 
secondary compared to primary  -10.88 (-17.53--4.24) 3.39 0.001 
Socio-economic score (centred) -6.24 (-11.11--1.38) 2.47 0.012 
Marital status:    
Divorced compared to married  5.78 (-1.26-12.82) 3.59 0.107 
Single compared to married 12.72 (2.80-22.65) 5.06 0.012 
Widowed compared to married  3.41 (-5.76-12.60) 4.68 0.465 
*a lower test score indicates better function 
 F=21.04; p=0.000; R2=10.61% 
 
 
3.3.2.3 Association between demographic factors and the colour trails 1 test score 
 
The overall variation in the colour trails test score explained by its linear relationship with the 
demographic factors in table 11 below is 16.0% hence 84.0% of the variation in the colour 
trails 1 test remains unexplained. Participants from the Masaka study site on average took 4.78 
seconds less (showing better speed of processing) to complete the colour trails 1 test in 
comparison to participants from the Entebbe region.  
 
 
 
 
 
 
Table 11: Multiple linear regression analysis for the association between demographic 
factors and the colour trails 1 test score 
 
The colour trails 1 test* (cons=89.17 seconds) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) 0.47 (0.26-0.69) 0.11 0.000 
Gender: 
   
male compared to female -6.17 (-10.76--1.88) 2.33 0.009 
Education:  
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None compared to primary 28.72 (22.25-35.19) 3.26 0.000 
secondary+ compared to primary -14.34 (-18.84--9.83) 2.31 0.000 
Socio-economic score (centred) -4.86 (-8.46--1.26) 1.83 0.001 
Study site     
Masaka compared to Entebbe -4.78 (-89.11--0.45) 2.21 0.024 
*a lower test score indicates better function 
F=28.86; p=0.000; R2=16.03% 
 
 
3.3.2.4 Association between demographic factors and the colour trails 2 test score 
 
For every unit increase in the socio-economic score, the colour trails 2 test score decreased by 
6.51 seconds suggesting improved executive function when adjusting for the demographic 
factors listed in table 12 below. A Sheehan disability scale score of 1 point higher on average 
resulted in a 0.67 second longer to complete the colour trails 2 test. The total variation in the 
colour trails 2 test score explained by its linear relationship with the demographic factors listed 
in the table below is 9.2%, much of the variation in the colour trails 2 test (90.8%) remains 
unexplained. Adjusting for the participants’ study site and religion did not significantly 
improve the fit of the colour trails 2 score model (p>0.10). 
 
 
 
 
 
Table 12: Multi-linear regression analysis for the association between demographic 
factors and the colour trails 2 test score 
 
The colour trails 2 test * (cons=143.56 seconds) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) 0.28 (-0.07-0.64) 0.18 0.118 
Gender:  
   
male compared to female -10.18 (-17.49--2.86) 3.72 0.006 
Education: 
   
none compared to primary 30.91 (20.70-41.11) 5.19 0.000 
secondary compared to primary  -10.89 (-17.88--3.91) 3.55 0.002 
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Socio-economic score (centred) -6.51 (-11.70 --1.33) 0.43 0.014 
Sheehan disability scale (centred) 0.67 (0.23-1.12) 2.64 0.003 
*a lower test score indicates better functioning 
F=15.16; p=0.000; R2=9.18% 
 
 
3.3.2.5 Association between demographic factors and the auditory verbal learning test  
 
The total variation in the auditory verbal learning test score explained by its linear relationship 
with the demographic factors listed in the equation above is 4.5%. Most of the variation 
(95.5%) in the auditory verbal learning test score remains unexplained.  Individuals who had a 
point score higher for general functional impairment in the Sheehan disability score, on average 
scored 0.11 points less in the auditory verbal learning test. Divorced participants were likely to 
have better verbal learning and memory function (Coef=1.44; 95% CI=0.30-2.57) than married 
participants.  
 
 
 
 
 
 
 
Table 13: Multi-linear regression analysis for the association between demographic 
factors and the auditory verbal learning test score 
 
The Auditory verbal learning test (cons=36.59 points) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) -0.08 (-0.13--0.03) 0.03 0.002 
Gender: 
   
male compared to female -1.14 (-2.23--0.05) 0.56 0.041 
Education: 
   
none compared to primary -1.80 (-3.29--0.31) 0.76 0.018 
secondary compared to primary  1.42 (0.36-2.47) 0.54 0.009 
Marital status    
Divorced compared to married 1.44 (0.30-2.57) 0.58 0.013 
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Single compared to married 0.66 (-0.95-2.27) 0.82 0.421 
Widowed compared to married  -0.61 (-2.09-0.87) 0.75 0.419 
Sheehan disability score (centred) -0.11 (-0.18--0.05) 0.35 0.001 
F=8.52; p=0.000; R2=4.52% 
 
 
3.3.2.6 Association between demographic factors and the digit span test score 
 
The results from the multiple linear regression model show that participants from Masaka 
region on average scored 0.61 points lower in the digit span test in comparison to participants 
from Entebbe region. 
 
 
 
 
 
 
 
 
 
Table 14: Multi-linear regression analysis for the association between demographic 
factors and the digit span test score 
 
The digit span test (cons=7.47 points) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) -0.02 (-0.04--0.00) 0.01 0.043 
Gender:    
male compared to female -0.05 (-0.48-0.39) 0.19 0.830 
Education: 
   
none compared to primary -1.59 (-2.19--1.00) 0.30 0.000 
secondary compared to primary  1.49 (0.94-1.81) 0.22 0.000 
Study site: 
   
Masaka compared to Entebbe  -0.61 (-0.98--0.23) 0.09 0.002 
F=21.67; p=0.000; R2=10.77% 
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3.3.2.7 Association between demographic factors and the symbol digit modalities test 
score 
 
The overall model to predict the symbol digit modalities test score was highly significant 
(F=39.51; p=0.000). However only 16.1% of the variation in the symbol digit modalities test 
score was explained by its linear relationship to age, gender, education and marital status. The 
study site, Sheehan disability score and socio-economic index explanatory variables did not 
improve the fit of the symbol digit modalities test score model, hence they were omitted 
(p>0.10). Divorced individuals were likely to have poorer speed of processing (coef 1.75; 95% 
CI=0.49-3.02) in comparison to married individuals.  
 
 
 
 
 
 
 
Table 15: Multi-linear regression analysis for the association between demographic 
factors and the symbol digit modalities test score 
 
The symbol digit modalities test* (cons=16.54 points) 
 
Adjusted Coef (95% CI) Std error p-value 
Age (centred) -0.07 (-0.13--0.02) 0.03 0.009 
Gender:    
male compared to female -0.24 (-0.13-0.02) 0.62 0.694 
Education: 
   
none compared to primary -6.00 (-0.62--15.72) 0.95 0.000 
secondary compared to primary 6.10 (4.93-7.27) 0.60 0.000 
Marital status:    
Divorced compared to married 1.75 (0.49-3.02) 0.65 0.007 
Single compared to married  1.40 (-0.39-3.18) 0.91 0.126 
Widowed compared to married  0.05 (-1.58-1.67) 0.84 0.953 
*a lower test score indicates better function 
F=39.51; p=0.000; R2=16.12% 
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3.3.3. Relationship between the neurocognitive assessment test scores and the IHDS 
score  
 
A sensitivity analysis was conducted to determine the most suitable model to describe the 
relationship between the neurocognitive assessment test scores and the IHDS score. In the first 
model, the IHDS score was treated as a continuous variable, in the second model the IHDS was 
treated as a binary variable as described in table 3 (variable 21) and the third model, the IHDS 
score was treated as an ordinal outcome variable as described in table 3 (variable 20). The 
results of the sensitivity analysis are presented in Appendix C of the report. Due to the 
distribution of the IHDS score the model that best described the relationship between the 
neurocognitive assessment test scores and the IHDS scores was the one with the IHDS as an 
ordinal outcome variable. For each neurocognitive score measured in seconds (i.e. grooved 
peg, colour trails 1 &2), the score was divided by 20 for ease of interpretation. The results from 
the univariable and multivariable ordinal regression models to assess the relationship between 
the neurocognitive assessment test scores (adjusted for age, gender and education) and the 
IHDS score are presented in table 16 below.  
 
For the univariable models, there was a significant relationship between all the neurocognitive 
test scores and the IHDS score, except for the timed gait test scores. The multivariable model 
was found to be highly significant (F=179.87; p<0.001). In the multivariable model there was 
no significant relationship between the following neurocognitive tests: timed gait, colour trails 
1, colour trails 2, symbol digit modalities and the variation in the IHDS scores (p>0.05).  
 
The odds of performing better in the IHDS decreased by 0.92 for each 20-second increase in 
time taken to complete the grooved pegboard test. For every 1-point increase in the auditory 
verbal learning test score, the odds of performing better in the IHDS test increased by 1.05 
participants. Participants who scored higher in the digit span test were more likely (OR=1.18, 
95%CI= 1.13-1.24) to score higher in the IHDS test when adjusting for all the neurocognitive 
test scores listed in the model below.  
 
Table 16: Univariable and Multiple ordinal logistic regression models to assess the 
relationship between the neurocognitive assessment test scores and the IHDS score  
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Univariable analysis  Multivariable analysis  
 
OR 95%CI p-value OR 95%CI p-value 
Timed gait * 0.79 (0.41-1.55) 0.497 0.55 (0.26-1.15) 0.114 
Grooved peg total * 0.87 (0.83-0.91) 0.000 0.92 (0.86-0.97) 0.002 
Colour trails 1 * 0.89 (0.83-0.96) 0.001 1.05 (0.94-1.17) 0.419 
Colour trails 2* 0.91 (0.87-0.96) 0.000 0.97 (0.91-1.03) 0.329 
Auditory verbal learning   1.07 (1.05-1.08) 0.000 1.05 (1.03-1.07) 0.000 
Digit span total  1.23 (1.19-1.29) 0.000 1.18 (1.13-1.23) 0.000 
Symbol digit modalities* 1.03 (1.02-1.05) 0.000 1.01 (0.99-1.02) 0.292 
*a lower test score indicates better functioning 
 
     
 
 
 
 
3.4 Determining how well the neurocognitive assessment test scores predict the IHDS 
outcome 
 
Out of the 1115 participants that underwent HIV dementia screening using the International 
HIV dementia scale, 73.25% of the study participants were identified to be at risk of 
developing HAD.  
 
3.4.1 Determining how well the neurocognitive tests predict the IHDS outcome 
(univariable analysis) 
 
Table 17 shows the ability of each of the neurocognitive tests to predict participants at risk of 
developing HAD. A post estimation graph plot of the sensitivity/specificity versus probability 
cut-off was the plotted to obtain the optimal cut-off point The digit span test was identified to 
have the highest predictive capacity among all the tests (AUC=66.40), however the test’s 
ability to identify participants at risk of developing HAD was one of the lowest 
(sensitivity=55.50%). The colour trails test to assess executive function showed the highest 
ability to identify participants at risk of developing HAD (sensitivity =82.42%), however the 
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test showed very low ability to identify participants that were not at risk of developing HAD 
(specificity=22.34%). 
 
Table 17: Univariable ROC analysis to determine how well the neurocognitive tests 
predict the IHDS outcome 
 
 
TGT GPD CT1 CT2 AVLT DIGTSP SYMDIG 
Optimal cut-off 0.73 0.71 0.72 0.70 0.74 0.76 0.74 
Area under the curve  56.37% 55.92% 53.55% 56.44% 63.34% 66.40% 58.38% 
Sensitivity 56.58% 46.58% 72.11% 82.42% 55.30% 55.50% 49.16% 
Specificity 55.89% 61.77% 31.16% 22.34% 64.09% 69.02% 61.05% 
TGT-timed gait, GPD-grooved pegboard, CT1-colour trails1, CT2-colour trails 2, AVLT-auditory verbal learning, DIGTSP-digit span, 
SYMDIG-symbol digit modalities 
 
 
 
 
 
3.4.2 Determining how well the neurocognitive tests predict the IHDS outcome 
(Multivariable analysis) 
 
Table 18 shows the combined ability of each the neurocognitive tests to predict participants at 
risk of developing HAD. A multivariable logistic regression model containing all the seven 
neurocognitive tests (adjusted for age, education and gender) was fitted to estimate the 
predicted probabilities to use as the classification variable in the ROC analysis. The predictive 
power of the neurocognitive tests was high (71%). The neurocognitive tests had a specificity 
~65% showing fair ability to identify participants that were not at risk of developing HAD and 
fairly adequate capacity to identify participants that were at risk of developing HAD (sensitivity 
~65%). 
 
Table 18: Multiple ROC analysis to determine how well the neurocognitive tests predict 
the IHDS outcome 
 
 
Neurocognitive battery 
Optimal cut-off 0.73 
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Area under the curve  70.25% 
Sensitivity 64.62% 
Specificity 66.67% 
Neurocognitive battery comprised of all seven tests   
 
3.5 Performance of the IHDS in the Ugandan population  
 
Using the neurocognitive battery and the Frascati criteria (See appendix A and appendix B), 
the prevalence of HAND in this study population was 9.10% whereas the IHDS had identified 
73.25% of the study population to be at risk of developing HAD. Using the parametric method 
(see table 19 and figure 13-14), the IHDS was found to have very high specificity (91%) hence 
high ability to identify participants without HAND however the scale was found to have a very 
low ability to identify participants with HAND (sensitivity=35%). Using the non-parametric 
method, at a cut-off point of 10 points, the sensitivity and specificity results were similar to 
those obtained in the parametric method. When the cut-off point was adjusted to 7 points, the 
IHDS validity was as follows: sensitivity=65.66%; specificity=58.52%. 
Table 19: ROC analysis (parametric method) for the validity of the IHDS detecting 
HAND 
 
 
IHDS 
Optimal cut-off 0.15 
Area under the curve  67.45% 
Sensitivity 34.54% 
Specificity 90.74% 
Neurocognitive battery comprised of all seven tests   
 
 
Table 20: ROC analysis (non-parametric method) for the validity of the IHDS detecting 
HAND 
 
 
IHDS (non-parametric 1) IHDS (non-parametric 2) 
Cut point  10 7 
Sensitivity 34.54% 65.66% 
Specificity 90.74% 58.52% 
Neurocognitive battery comprised of all seven tests    
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Figure 13: Sensitivity/specificity probability cut-off plot for validity of the IHDS in 
detecting HAND 
 
 
Figure 14: Sensitivity-specificity plot for validity of the IHDS in detecting HAND 
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 CHAPTER 4: DISCUSSION 
 
In this discussion chapter, a brief overview of the results will be provided. The chapter will 
further discuss the association between demographic factors and neurocognitive test scores. 
Following this, the relationship between the neurocognitive test scores and the IHDS as well 
as the performance of the IHDS in the Ugandan population will be discussed. To conclude the 
report, the strengths and limitations of the study as well the conclusions and recommendations 
drawn from the study will be outlined.  
 
4.1 Overview of the study findings 
 
In this study, the primary objective was to investigate whether the neurocognitive test battery 
(made up of the following neurocognitive assessment tests: the timed gait test, the WHO-UCLA 
verbal learning test, the grooved pegboard test, the colour trails 1 & 2 test, the Auditory verbal 
learning test, the digit span backward and forward test and the symbol digit modalities test) 
would be appropriate to detect HAND in the absence of normative data in a Ugandan cohort. 
The study has revealed several useful findings including: 
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 Demographic variables: ageing, being female, having a lower socio-economic score 
and having lower levels of education were associations for poor neurocognitive 
performance in PLWHA.  
 The neurocognitive test battery discriminated moderately between PLWHA who were 
at risk of HAD and those who were not at risk.  
 The recommended IHDS to screen for HAND demonstrated poor validity in the 
Ugandan context.  
Each of these findings will be discussed in detail below. 
 
4.2 Association between demographic factors and the neurocognitive test scores\ 
 
Increasing age, lower education levels, the female, and being from the Masaka region were 
identified as important predictors of neurocognitive impairment across all domains. However, 
the results of the study suggest that not all neurocognitive measures in the administered 
neurocognitive battery were as strongly associated with these demographic factors. Advanced 
age and low education were associated with poorer neurocognitive performance across nearly 
all neurocognitive measures. Education in particular, affected neurocognitive performance on 
tests of gross motor function, fine motor function, speed of processing and attention/working 
memory. Executive function while sensitive to education was not affected by age but age was 
significantly associated with a decline in all other neurocognitive domains.  
 
4.2.1 Association between age and the neurocognitive test scores 
 
Previous studies have revealed similar trends of the effect of age and education on 
neurocognitive performance (9,12). Valcour et al. reported a threefold increase in 
neurocognitive impairment in participants older than 50 years to participants who were aged 
between 20-39 years independent of other demographic factors. The confounding effect of age 
on neurocognitive impairment has however not been consistent in all studies. Cysique and 
colleagues assessed cognitive function in 146 patients in Australia and found no significant 
neurocognitive impairment differences based on age differences (57). The authors of the study 
suggested participants who were infected with HIV at a higher age to have more rapid 
neurocognitive decline and advised future studies to explore the neurocognitive effect of HIV 
66 
 
and age on a larger sample. In the present study, a larger sample size was employed to address 
this recommendation. 
 
4.2.2 Association between gender and the neurocognitive test scores 
 
An interesting finding is that being female was significantly associated with poor performance 
in the following neurocognitive domains: gross motor function, fine motor function, speed of 
processing, executive function however; there was no significant association between gender 
and the verbal learning/working memory cognitive domain. This finding is different to findings 
from previous studies where  gender was found to not affect neurocognitive performance in 
PLWHA   (57,58). In a study by Welsh-Bohmer and colleagues, the investigators examined 
neurocognitive performance of participants without illness and the results revealed gender to 
have negligible effects on neurocognitive performance when adjusting for age and education 
(58). In the present study, it is not clear why there a variation in neurocognitive performance 
was observed between the two genders even after controlling for age and education, we suspect 
a possibility of females having comorbidities such as depression as revealed in a study on the 
same cohort (42). The difference in findings could be attributed to variation in testing 
standards, cultural context as well as differing demographic distribution based on sample size 
or chance. 
 
 
 
4.2.3 Association between education and the neurocognitive test scores 
 
Participants with lower education levels were found to have poorer cognitive function across 
all neurocognitive measures. Our results were consistent with several studies which explored 
the effect of education on neurocognitive performance in PLWHA (12,28,37,46). We suspect 
familiarity with testing formats in educated individuals to contribute to their ability to follow 
instructions and complete tasks (Boone, 2007). It is important to note that in the present study 
the ‘education’ variable was categorised. Previous studies have reported the need to consider 
quality as well as years of schooling when investigating the effects of education on 
neurocognitive performance. In an Australian study on an HIV positive cohort, Manly et al. 
compared the effect of education as a categorical variable and ‘reading level’ as a measure of 
quality of education on neurocognitive performance (24,59). The study revealed quality of 
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education to account for the most variance in neurocognitive performance in comparison to 
education category, HIV status and age (24). 
 
4.2.4 Association between place of residence/socio-economic index and the 
neurocognitive test scores  
 
Our results also suggest variation in neurocognitive performance between the two study sites. 
Participants from the Masaka region (mean socio-economic index=0.92±0.5) had poorer 
performance in neurocognitive measures of gross motor function, speed of processing and 
attention/working memory in comparison to participants from Entebbe region (mean socio-
economic index=1.41±3.6).  
 
It is worth emphasizing that to accentuate that participants from the Masaka area had a lower 
socio-economic index in comparison to participants from the Entebbe area, hence our study 
reveals that low socio-economic status to be associated with poor neurocognitive performance 
in PLWHA. These findings are similar to that of da Rosa and colleagues who conducted a 
systematic review of investigations that examined the relationship between socio-economic 
status and neurocognitive performance (60). In this systematic review low socio-economic 
status was associated with poor performance in neurocognitive measures of visio-spatial 
function, executive function and attention/memory and stress was found to mediate the 
relationship between socio-economic status and neurocognitive performance (60). However, 
the studies reviewed by da Rosa and colleagues consisted of HIV negative cohorts, the 
relationship between socio-economic status, stress and neurocognitive performance ought to 
be explored in an HIV infected population. We also suspect socio-economic status to be a 
surrogate marker for access to education which has been found to be associated with 
neurocognitive performance (28,37).  
 
These findings on the association between demographic factors and neurocognitive 
performance have biological plausibility. In a review on the pathogenesis of HIV associated 
neurocognitive disorders, Saylor and colleagues pooled the results of several HAND studies 
and suggested, the HIV virus triggers inflammation of the cerebrospinal fluid which triggers 
the neuronal cells of the brain that transmit and receive signals to execute tasks to undergo a 
decline in dendritic arborisation (41,61). Dendritic arborisation is the organization of the cell 
body of the neuron and its dendritic processes that enable cognitive tasks to be performed (62). 
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Cerebrospinal inflammation is also reported to occur in the aging brain, which could explain 
the results of the study concerning the patterns of neurocognitive performance in aging 
participants (35). 
 
4.3 Association between the neurocognitive test scores and the IHDS  
 
The third of objective of the study was to investigate the relationship between neurocognitive 
test scores and the IHDS and to determine how well the neurocognitive test scores predict the 
IHDS score/outcome.  
 
Our results suggest a significant association between the IIHDS and the following 
neurocognitive measures: timed gait test-to assess gross motor function, grooved pegboard 
test-to assess fine motor function, auditory verbal learning test-to assess verbal learning and 
memory ability, and the digit span test to assess attention/working memory. There was no 
association between the IHDS and the colour trails 1 test/symbol digit modalities test-to assess 
speed of processing and the colour trails 2 test-to assess executive function. To the best of our 
knowledge, there are no studies that have explored how well the neurocognitive battery predicts 
the IHDS outcome. Previous studies have used the neurocognitive battery as the gold standard 
to investigate the validity of the IHDS but have however not reported how each of the tests of 
the neurocognitive battery relate to the IHDS outcome (19,20,37,63) 
 
 The IHDS assesses the memory and motor function domains, hence we hypothesized a direct 
correlation between the IHDS scores and neurocognitive measures for the memory domain (i.e. 
auditory verbal learning and digit span tests) and neurocognitive measures for the motor 
function domain (i.e. the timed gait and grooved pegboard tests). Our results support this 
hypothesis for neurocognitive measures of motor function (i.e. timed gait and grooved 
pegboard test) however there was an inverse relationship between the neurocognitive measures 
that assess the memory domain (i.e. auditory verbal learning and digit span tests) and the IHDS. 
We suspect this inverse relationship to be attributed to the difference in the quantity of 
questions assessing the memory domain between the IHDS and the neurocognitive tests. While 
a participant is required to recall 15 words in the auditory verbal leaning test, a participant is 
only required to recall four words for the IHDS to assess memory. There is a possibility of 
participants being able to perform better in a brief word recall test as opposed to a longer word 
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recall tests, which could explain the results found in the present study. Variation in 
neurocognitive performance using different tests ought to be explored further. 
 
4.4 Performance of IHDS in the Ugandan population 
 
The high prevalence of HAD (73.25%) led to us to question the validity of the IHDS in this 
study population. Using the gold standard for HAND diagnosis (neurocognitive battery and 
published normative scores) we found the prevalence of HAND in the study population to be 
9.10% yet the results from the IHDS revealed 73.25% of the study population to be at risk of 
developing HIV associated dementia, the most severe form of HAND. The IHDS was found to 
discriminate poorly among participants with HAND and those without even after adjusting cut-
offs. Our findings differ from previous findings on the validity of the IHDS in similar 
populations (19,20,37). In 2005, Sacktor and colleagues investigated the validity of the IHDS 
in the Ugandan context and found the IHDS to discriminate satisfactorily among participants 
with HAND and those without with a sensitivity of 80% and a specificity of 55% at a cut-point 
of 10 points. However the study sample in the study by Sacktor et al. was small and 
neurocognitive scores were not adjusted for demographic factors which may have led to the 
overestimation of the prevalence of HAND and in turn the validity of the IHDS (19). 
 
Our study differs from previous studies on the validity of the IHDS in similar contexts.  
However, our findings do however support the suggestion made by Dang et al of exploring 
different diagnostic cut-off points for the IHDS to take into account the variation of the IHDS 
accounted for by demographic differences reported in several studies and also seen in the 
present study (37,63,64). It is worth noting that the current recommendation by the 
international community of a diagnostic cut-off of 10 points on the IHDS does not include the 
influence of educational level, age, ethnicity, and other sociocultural factors in its definition. 
We suspect the cut-off score of 10 points to lead to the emergence of false positives when 
applied to HAND diagnoses in underdeveloped regions as seen in the present study. 
 
4.5 Strengths and limitations 
 
The strength of this study lies in the fact that the information gathered is derived from a large 
carefully examined sample where rigorous data collection methods were employed to ensure 
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little missing data. It is our belief that the study contributes to our knowledge about HAND 
diagnosis in Sub Saharan Africa. 
 
There are several epidemiological, technical and statistical limitations to the study, which are 
described below: 
 
 As this study was a cross sectional study, the cause for poor neurocognitive 
performance cannot be determined from the associations identified. 
 The neurocognitive assessment tools in the present study were not taken through a 
formal validation process, however the tools were taken through  forward and backward 
translation process to meet a threshold reliability (42). 
 Based on previous studies on neurocognitive performance in resource-limited settings, 
cultural contexts were found to contribute to substantial variation in neurocognitive 
performance (Robertson et al., 2016). Therefore, generalizability of the current study 
results may be limited due to the cultural context of the study participants.  
 The use of the IHDS to screen for HAND posed a limitation in answering the study 
question as the IHDS was found to have poor validity in detecting HAND in the 
Ugandan context. Using the IHDS as the reference test to determine whether 
neurocognitive test scores could be used to detect HAND in the absence of normative 
data could have led to an overestimation or underestimation of the ability of 
neurocognitive assessment tests to screen for HAND in the absence of normative data.  
 The HAND outcome of participants was determined using solely statistical means 
without the expertise of a psychiatrist to confirm diagnosis; hence, there is a possibility 
of misdiagnosis.  
 The amount of variation in the neurocognitive test scores accounted for by the 
demographic factors recorded in this study was minimal; inclusion of clinical 
biomarkers such as CD4 count, comorbid conditions and HIV clade would have 
strengthened the neurocognitive test score models.  
 There is a possibility that the HIV infected participants may have had undetected 
aetiologies that have the potential to impair cognitive ability such as syphilis or malaria 
(65–67).  
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 The inability to rule out opportunistic central nervous system infections using 
neuroimaging technology may have led us to overestimate the prevalence of HAND 
(36).  
 Normative data to assess the construct validity of the IHDS in the Ugandan population 
was obtained from a published study on neuropsychological normative scores for 
resource limited populations (28). This study highlights the need for country based 
normative data shown by the cross-cultural variation in neuropsychological 
performance in the participants of this study. The use of data from this study in which 
a Ugandan population was not included could have led to false estimates of the validity 
of the IHDS in the Ugandan population. 
 
4.6 Conclusion and recommendations  
 
In conclusion, the present study shows an overall poor performance in the cognitive domains 
of speed of processing, executive function, attention/working memory among HIV infected 
participants. Low education and advanced age were associated with poorer neurocognitive 
performance. The present study also underscores the importance of age, gender, education 
marital status, religion and place of residence as important markers for neurocognitive 
performance. The neurocognitive test battery used in the present study discriminated modestly 
among HIV participants at risk of developing HIV associated dementia and those that were not 
at risk of developing dementia. In the Ugandan population, the construct validity of the IHDS 
in the diagnosis of HAND was poor. 
 
While there needs to be further work done to obtain country based normative data, 
comprehensive neurocognitive testing that involves normative data is not feasible for routine 
HAND screening. Further work is required to produce an algorithm to detect HAND in the 
absence of normative data. This includes an inclusion of important clinical biomarkers, 
exploration of further demographic confounders as well strengthening of the HAND diagnostic 
criteria using the neuropsychological test battery. Development of algorithms to detect HAND 
in resource-limited settings is essential in order to understand the HAND burden in the face of 
a high prevalence of HIV seen in these settings.  
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Appendix A: The Frascati Criteria for the classification of HIV associated neurocognitive disorders 
 
 
 HIV Associated Asymptomatic Neurocognitive 
Impairment (ANI) 
 
1. Acquired impairment in cognitive functioning must involve at least two ability domains, 
documented by performance of at least 1.0 standard deviation below the mean for 
age-education-appropriate norms on standardized neuropsychological tests.  The 
neuropsychological assessment must survey at least the following 
abilities:  verbal/language, attention/working memory, abstraction/executive, memory 
(learning/ recall), speed of information processing, sensory-perceptual, motor skills. 
2. The cognitive impairment does not interfere with everyday functioning. 
3. The cognitive impairment does not meet criteria for delirium or dementia. 
4.  There is no evidence of another pre-existing cause (like depression or substance abuse) 
for the ANI. 
 
  
 HIV-1 Associated Mild Neurocognitive 
Disorder (MND) 
 
1.  Acquired impairment in cognitive functioning must involve at least two ability domains, 
documented by performance of at least 1.0 standard deviation below the mean for 
age-education-appropriate norms on standardized neuropsychological tests.  The 
neuropsychological assessment must survey at least the following abilities: verbal/language; 
attention/working memory; abstraction/executive; memory (learning; recall), speed of 
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information processing, sensory-perceptual, motor skills. Typically, this would correspond 
to a Memorial Sloan Kettering (MSK) scale stage of 0.5 – 1.0  
2. The cognitive impairment produces at least mild interference in daily functioning (at least 
one of the following): 
i. Self-report of reduced mental acuity, inefficiency in work, homemaking, or social 
functioning. 
ii. Observation by knowledgeable others that the individual has undergone at least mild 
decline in mental acuity with resultant inefficiency in work, homemaking, or social 
functioning.  
3. The cognitive impairment does not meet criteria for delirium or dementia. 4. There is no 
evidence of another pre-existing cause for the MND. 
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HIV-1 Associated Dementia (HAD) 
 
1. There is marked acquired impairment in cognitive functioning, involving at least two 
ability domains; typically, the impairment is in multiple domains, especially in learning of 
new information, slowed information processing, and defective attention/concentration.  
2. The cognitive impairment must be ascertained by neuropsychological testing with at least 
two domains 2 SD or greater than demographically corrected means. (If neuropsychological 
testing is not available, standard neurological evaluation and simple bedside testing may be 
used, but this should be indicated in algorithm ~ see below).  
3. The cognitive impairment produces marked interference with day-to-day functioning 
(work, home life, social activities). 
4. The marked cognitive impairment has been present for at least one month. 
5. The pattern of cognitive impairment does not meet criteria for delirium (e.g., clouding of 
consciousness is not a prominent feature); or, if delirium is present, criteria for dementia 
need to have been met on a prior examination when delirium was not present. 
6. There is no evidence of another, pre-existing cause for the dementia (e.g., other CNS 
infection, CNS neoplasm, cerebrovascular disease, pre-existing neurological disease, or 
severe substance abuse compatible with CNS disorder). 
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Appendix C: Sensitivity analysis for the association between neurocognitive test scores 
and the IHDS score  
 
 
Table 1: Univariable and Multiple linear regression models to assess the relationship 
between the neurocognitive assessment test scores and the IHDS score  
 
 
Univariable analysis  Multivariable analysis  
 
Coef  (95%CI) p-value Coef (95%CI) p-value 
Timed gait * -0.01 (-0.27-0.01) 0.214 0.01 (-0.00-0.03) 0.081 
Grooved peg total * -0.01 (-0.01--0.01) 0.000 0.00 (0.00-0.01) 0.000 
Colour trails 1 * -0.01 (-0.01--0.01) 0.000 0.00 (-0.00-0.00) 0.610 
Colour trails 2* -0.01 (-0.01--0.00) 0.000 -0.00 (-0.00-0.00) 0.023 
Auditory verbal learning   0.06 (0.05-0.07) 0.000 0.03 (0.02-0.05) 0.000 
Digit span total  0.17 (0.14-0.19) 0.000 0.11 (0.08-0.14) 0.000 
Symbol digit modalities* 0.02 (0.01-03) 0.000 0.00 (-0.01-0.01) 0.896 
*a lower test score indicates better functioning 
 
 
 
Table 2: Univariable and multivariable binary logistic regression models to assess the 
relationship between the neurocognitive assessment test scores and the IHDS score  
 
 
Univariable analysis  Multivariable analysis  
 
OR  (95%CI) p-value OR (95%CI) p-value 
Timed gait * -0.02 (-0.04-0.01) 0.326 -0.03 (-0.06--0.00) 0.027 
Grooved peg total * 0.01 (0.00-0.01) 0.000 0.00 (0.00-0.01) 0.049 
Colour trails 1 * 0.01 (0.01-0.01) 0.015 -0.00 (0.01-0.00) 0.414 
Colour trails 2* 0.00 (0.01-0.01) 0.002 0.00 (-0.00-0.01) 0.518 
Auditory verbal learning   -0.06 (-0.08--0.04) 0.000 -0.04 (-0.06--0.02) 0.000 
Digit span total  -0.19 (-0.24--0.14) 0.000 -0.16 (-0.21--0.11) 0.000 
Symbol digit modalities* -0.03 (-0.04--0.02) 0.000 -0.11 (-0.03-0.01) 0.217 
*a lower test score indicates better functioning 
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Table 3: Univariable and Multiple ordinal logistic regression models to assess the 
relationship between the neurocognitive assessment test scores and the IHDS score  
 
 
Univariable analysis  Multivariable analysis  
 
OR 95%CI p-value OR 95%CI p-value 
Timed gait * 0.79 (0.41-1.55) 0.497 0.55 (0.26-1.15) 0.114 
Grooved peg total * 0.87 (0.83-0.91) 0.000 0.92 (0.86-0.97) 0.002 
Colour trails 1 * 0.89 (0.83-0.96) 0.001 1.05 (0.94-1.17) 0.419 
Colour trails 2* 0.91 (0.87-0.96) 0.000 0.97 (0.91-1.03) 0.329 
Auditory verbal learning   1.07 (1.05-1.08) 0.000 1.05 (1.03-1.07) 0.000 
Digit span total  1.23 (1.19-1.29) 0.000 1.18 (1.13-1.23) 0.000 
Symbol digit modalities* 1.03 (1.02-1.05) 0.000 1.01 (0.99-1.02) 0.292 
*a lower test score indicates better functioning 
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Appendix D: Graphical plots showing optimal cut-offs for how well neurocognitive test 
scores predicted the IHDS outcome   
 
 
 
 
Figure 1: Optimal cut-off for the timed gait score in predicting IHDS outcome  
 
 
Figure 2: Optimal cut-off for the grooved-peg score in predicting IHDS outcome  
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Figure 3: Optimal cut-off for the colour trails 1 score in predicting IHDS outcome  
 
 
 
Figure 4: Optimal cut-off for the colour trails 2 score in predicting IHDS outcome  
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Figure 5: Optimal cut-off for the auditory verbal learning score in predicting IHDS 
outcome  
 
 
Figure 6: Optimal cut-off for the digit span score in predicting IHDS outcome  
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Figure 7: Optimal cut-off for the symbol digit modalities score in predicting IHDS 
outcome  
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